<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="mtm" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">mtm</book-part-id>
      <title-group>
        <title>X-Linked Centronuclear Myopathy</title>
        <alt-title alt-title-type="alt-title">Synonyms: X-Linked Myotubular Myopathy, XLCNM, XLMTM</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Das</surname>
            <given-names>Soma</given-names>
          </name>
          <degrees>PhD</degrees>
          <aff>Department of Human Genetics <break/>University of Chicago<break/>Chicago, Illinois</aff>
          <email>sdas@genetics.uchicago.edu</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Dowling</surname>
            <given-names>James</given-names>
          </name>
          <degrees>MD, PhD</degrees>
          <aff>Division of Pediatric Neurology<break/>University of Michigan<break/>Ann Arbor, Michigan</aff>
          <email>jamedowl@med.umich.edu</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Pierson</surname>
            <given-names>Christopher R</given-names>
          </name>
          <degrees>MD, PhD</degrees>
          <aff>The Research Institute at Nationwide Children&#x02019;s Hospital<break/>Columbus, Ohio</aff>
          <email>Christopher.Pierson@nationwidechildrens.org</email>
        </contrib>
      </contrib-group>
      <pub-history>
        <date iso-8601-date="2002-02-25" date-type="created">
          <day>25</day>
          <month>2</month>
          <year>2002</year>
        </date>
        <date iso-8601-date="2011-10-06" date-type="updated">
          <day>6</day>
          <month>10</month>
          <year>2011</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="xla" document-type="chapter">X-Linked Agammaglobulinemia</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="csnb" document-type="chapter">X-Linked Congenital Stationary Night Blindness</related-object>
      <abstract id="mtm.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p>X-linked centronuclear myopathy (XLCNM) (also known as myotubular myopathy [MTM]) is characterized by muscle weakness that ranges from severe to mild. Severe (classic) XLCNM presents prenatally with polyhydramnios and decreased fetal movement and in newborns with weakness, hypotonia, and respiratory distress. Affected males have significantly delayed motor milestones and most fail to achieve independent ambulation. Weakness is profound and often involves facial and extraocular muscles. Respiratory failure is nearly uniform, with most affected individuals requiring 24-hour ventilatory assistance. A minority of males with severe XLCNM die in infancy. Males with moderate XLCNM achieve motor milestones more quickly than males with the severe form; about 40% require no ventilator support or intermittent support. Males with mild XLCNM may require ventilatory support only in the newborn period; they have minimally delayed motor milestones, are able to walk, and may lack myopathic facies. The muscle disease of XLCNM is not obviously progressive. Female carriers of XLCNM are generally asymptomatic, although rare manifesting heterozygotes have been described.</p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>The diagnosis of XLCNM relies upon identification of characteristic histopathologic changes in muscle samples from males with a consistent clinical picture and supporting genetic testing. In some individuals there is also a family history consistent with X-linked inheritance. <italic toggle="yes">MTM1</italic> is the only gene in which <italic toggle="yes">mutation</italic> is known to cause XLCNM. Molecular genetic testing of <italic toggle="yes">MTM1</italic> detects pathogenic variants in 60%-98% of affected individuals.</p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations</italic>: Treatment is symptomatic. Management optimally involves a team of specialists with expertise in the long-term care of children with neuromuscular disorders, often including a pulmonologist, neurologist, physical therapist and/or rehabilitation medicine specialist, and clinical geneticist. Tracheostomy, G-tube feeding, and assistive communication devices are often required. Ophthalmologists and orthopedists specializing in scoliosis management and orthodontists should address specific medical complications.</p>
          <p><italic toggle="yes">Prevention of secondary complications</italic>: Evaluation of clotting parameters is indicated prior to any surgical procedure.</p>
          <p><italic toggle="yes">Surveillance</italic>: Annual pulmonary assessment; polysomnography every one to three years; routine examination for signs of scoliosis; annual ophthalmologic examinations to evaluate for ophthalmoplegia, ptosis, and myopia; routine assessment for dental malocclusion.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p>XLCNM is inherited in an X-linked manner. The risk to sibs of a male proband depends on the carrier status of the mother. If the mother is a carrier, each sib has a 50% chance of inheriting the <italic toggle="yes">MTM1</italic> pathogenic variant. Males who inherit the variant will be affected; females who inherit the variant will be carriers and will generally not be affected. In simplex cases (i.e., a single occurrence in a family), there is a probability of 80%-90% that a woman is a carrier if her son has a confirmed <italic toggle="yes">MTM1</italic> pathogenic variant. Thus, about 10%-20% of males who represent simplex cases have a <italic toggle="yes">de novo</italic> pathogenic variant in <italic toggle="yes">MTM1</italic> and a mother who is not a carrier. Germline mosaicism has been reported. Carrier testing of at-risk female relatives and prenatal testing for pregnancies at risk are possible if the <italic toggle="yes">MTM1</italic> pathogenic variant has been identified in an affected male relative.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="mtm.Diagnosis">
        <title>Diagnosis</title>
        <sec id="mtm.Clinical_Diagnosis">
          <title>Clinical Diagnosis</title>
          <p>The diagnosis of X-linked centronuclear myopathy (XLCNM) (also known as myotubular myopathy [MTM]) should be considered in any male with significant neonatal hypotonia and muscle weakness or in older males with diminished muscle bulk and extremity weakness particularly if any of the following are present:</p>
          <list list-type="bullet">
            <list-item>
              <p>A positive family history suggestive of X-linked inheritance (found in approximately 30% of reported individuals)</p>
            </list-item>
            <list-item>
              <p>Length and head circumference greater than the 90th centile, cryptorchidism, and/or long fingers and toes</p>
            </list-item>
            <list-item>
              <p>Involvement of the extraocular muscles (i.e. ophthalmoparesis)</p>
            </list-item>
          </list>
        </sec>
        <sec id="mtm.Testing">
          <title>Testing</title>
          <sec id="mtm.Muscle_Biopsy">
            <title>Muscle Biopsy</title>
            <p>
              <bold>Affected Males</bold>
            </p>
            <p><bold>Histopathologic</bold> findings:</p>
            <list list-type="bullet">
              <list-item>
                <p>The characteristic muscle biopsy demonstrates numerous small, rounded myofibers with varying percentages of centrally located nuclei. No diagnostic threshold of central nuclei has been established, as the percentage may increase over time. In rare instances, centrally located nuclei may be absent [<xref ref-type="bibr" rid="mtm.REF.de_goede.2005.835">de Goede et al 2005</xref>, <xref ref-type="bibr" rid="mtm.REF.pierson.2007.562">Pierson et al 2007</xref>].</p>
              </list-item>
              <list-item>
                <p>Periodic acid-Schiff (PAS) and nicotinamide adenine dinucleotide dehydrogenase-tetrazolium reductase histochemical staining often demonstrate an accumulation of staining product in the center of the small myofibers, which reflects maldistribution of glycogen and mitochondria, respectively [<xref ref-type="bibr" rid="mtm.REF.pierson.2005.555">Pierson et al 2005</xref>, <xref ref-type="bibr" rid="mtm.REF.romero.2010.223">Romero 2010</xref>].</p>
              </list-item>
              <list-item>
                <p>ATPase histochemical staining may show type 1 myofiber predominance or small type 1 and type 2A fibers alongside relatively larger type 2B fibers [<xref ref-type="bibr" rid="mtm.REF.pierson.2005.555">Pierson et al 2005</xref>]. In some biopsies ATPase staining demonstrates myofibers with central clearing that results from a focal absence of myofibrils [<xref ref-type="bibr" rid="mtm.REF.pierson.2005.555">Pierson et al 2005</xref>, <xref ref-type="bibr" rid="mtm.REF.romero.2010.223">Romero 2010</xref>].</p>
              </list-item>
              <list-item>
                <p>The histopathologic findings listed are not specific to XLCNM and may be encountered in congenital myotonic dystrophy type 1 (see <xref ref-type="sec" rid="mtm.Differential_Diagnosis">Differential Diagnosis</xref>) and in early onset autosomal forms of centronuclear myopathy. XLCNM with a low percentage of central nuclei and type 1 fiber predominance can also resemble congenital fiber type disproportion [<xref ref-type="bibr" rid="mtm.REF.pierson.2005.555">Pierson et al 2005</xref>].</p>
              </list-item>
            </list>
            <p>Note: (1) The clinical and histopathologic features of <italic toggle="yes">MTM1-</italic>associated myopathies are broad, requiring that a distinction be made between central and internal nuclei [<xref ref-type="bibr" rid="mtm.REF.romero.2010.223">Romero 2010</xref>]. The former occur at (or very near) the exact center of a myofiber and are typical of (although not specific for) XLCNM, whereas the latter are eccentrically situated within the myofiber. (2) Necklace fibers are a distinctive feature that has been described in sporadic late-onset <italic toggle="yes">MTM1</italic>-related XLCNM. Necklace fibers appear on hematoxylin-eosin stained sections as a basophilic ring-like deposit that follows the contour of the myofiber and aligns with internal myonuclei [<xref ref-type="bibr" rid="mtm.REF.bevilacqua.2009.283">Bevilacqua et al 2009</xref>]. They can also be visualized with succinate dehydrogenase histochemical staining [<xref ref-type="bibr" rid="mtm.REF.bevilacqua.2009.283">Bevilacqua et al 2009</xref>]. Necklace fibers may be accompanied by muscle hypotrophy and type 1 fiber predominance. The percentage of myofibers with internal nuclei frequently exceeds the percentage of fibers with central nuclei and both tend to increase with age. (3) Biopsies from older individuals may feature increased connective and adipose tissues.</p>
            <p><bold>Immunohistochemical stains</bold> on most (not all) muscle samples from individuals with XLCNM demonstrate persistence of fetal-specific muscle proteins or isoforms such as desmin, vimentin, and fetal myosin [<xref ref-type="bibr" rid="mtm.REF.sarnat.1990.109">Sarnat 1990</xref>, <xref ref-type="bibr" rid="mtm.REF.sewry.1998.394">Sewry 1998</xref>]. Variation in the immunohistochemical expression of NCAM, utrophin, laminin, alpha 5, and HLA1 antigen has also been described [<xref ref-type="bibr" rid="mtm.REF.helliwell.1998.152">Helliwell et al 1998</xref>]. The clinical utility of these immunostains has not been systematically studied.</p>
            <p>T-tubule disorganization visualized through immunohistochemistry has been recently described in XLCNM [<xref ref-type="bibr" rid="mtm.REF.alqusairi.2009.18763">Al-Qusairi et al 2009</xref>, <xref ref-type="bibr" rid="mtm.REF.dowling.2009.e1000372">Dowling et al 2009</xref>]. DHPRa1, a T-tubule protein, and RyR1, a sarcoplasmic recticulum protein, are abnormally distributed in myofibers with increased immunoreactivity appearing in the center of small fibers [<xref ref-type="bibr" rid="mtm.REF.dowling.2009.e1000372">Dowling et al 2009</xref>]. Since other centronuclear myopathies also have T-tubule defects the diagnostic utility of this finding may be limited [<xref ref-type="bibr" rid="mtm.REF.toussaint.2011.253">Toussaint et al 2011</xref>].</p>
            <p><bold>Immunologic testing</bold> using antibodies specific for myotubularin, the protein encoded by <italic toggle="yes">MTM1</italic> [<xref ref-type="bibr" rid="mtm.REF.laporte.2001b.42">Laporte et al 2001b</xref>], can detect the presence or absence of myotubularin in cell lines from affected individuals. In 21/24 males with known pathogenic variants, including some missense variants, no myotubularin was detected on western blot. One out of five boys with suspected XLCNM in whom no pathogenic variant was identified also had no detectable protein by western analysis. <xref ref-type="bibr" rid="mtm.REF.tosch.2010.375">Tosch et al [2010]</xref> demonstrated the absence of detectable protein in eight affected individuals with severe to intermediate phenotypes and a decreased amount of protein in an individual with a mild phenotype. Eight of nine individuals had confirmed <italic toggle="yes">MTM1</italic> pathogenic variants; one individual had no detectable protein and an intermediate phenotype, but no <italic toggle="yes">MTM1</italic> pathogenic variant was detected. While immunologic testing may be helpful in some individuals with suspected XLCNM in whom no pathogenic variant is found, such analysis is not routine, and adequate antibodies to myotubularin are not widely available.</p>
            <p>
              <bold>Carrier Females</bold>
            </p>
            <p>An abnormal muscle biopsy is found in 50%-70% of obligate carrier females [<xref ref-type="bibr" rid="mtm.REF.wallgrenpettersson.1995.673">Wallgren-Pettersson et al 1995</xref>]; thus, muscle biopsy studies are not sensitive enough for carrier testing.</p>
          </sec>
          <sec id="mtm.Molecular_Genetic_Testing">
            <title>Molecular Genetic Testing</title>
            <p><bold>Gene.</bold>
<italic toggle="yes">MTM1</italic> is the only gene in which pathogenic variants are known to cause XLCNM [<xref ref-type="bibr" rid="mtm.REF.wallgrenpettersson.2000.525">Wallgren-Pettersson 2000</xref>].</p>
            <p>
              <bold>Testing</bold>
            </p>
            <list list-type="bullet">
              <list-item>
                <p><bold>Sequence analysis</bold> of the 15 coding exons and flanking intron sequence [<xref ref-type="bibr" rid="mtm.REF.de_gouyon.1997.1499">de Gouyon et al 1997</xref>, <xref ref-type="bibr" rid="mtm.REF.laporte.1997.1505">Laporte et al 1997</xref>] is available clinically. In several series, pathogenic variants were detected in 60%-90% of individuals with XLCNM [<xref ref-type="bibr" rid="mtm.REF.de_gouyon.1997.1499">de Gouyon et al 1997</xref>, <xref ref-type="bibr" rid="mtm.REF.laporte.1997.1505">Laporte et al 1997</xref>, <xref ref-type="bibr" rid="mtm.REF.herman.2002.114">Herman et al 2002</xref>, <xref ref-type="bibr" rid="mtm.REF.tsai.2005.245">Tsai et al 2005</xref>]. In individuals with mild XLCNM, fewer than 20% of pathogenic variants are identified [<xref ref-type="bibr" rid="mtm.REF.bertini.2004.387">Bertini et al 2004</xref>] and may reflect the involvement of additional genes.</p>
              </list-item>
              <list-item>
                <p><bold>Pathogenic variant scanning</bold> techniques generally yield a variant detection rate of 60%-90% [<xref ref-type="bibr" rid="mtm.REF.wallgrenpettersson.1998.521">Wallgren-Pettersson 1998</xref>, <xref ref-type="bibr" rid="mtm.REF.tanner.1999b.41">Tanner et al 1999b</xref>, <xref ref-type="bibr" rid="mtm.REF.flex.2002.501">Flex et al 2002</xref>]. <xref ref-type="bibr" rid="mtm.REF.tanner.1999b.41">Tanner et al [1999b]</xref> reported a variant detection rate of 97%-98% using heteroduplex analysis. Their higher detection rate may reflect a more stringent selection of affected individuals as well as screening for non-coding variants.</p>
              </list-item>
              <list-item>
                <p><bold>Deletion/duplication analysis</bold>. Approximately 7% of pathogenic variants are large deletions of one or more exons of <italic toggle="yes">MTM1</italic> [<xref ref-type="bibr" rid="mtm.REF.laporte.2000.393">Laporte et al 2000</xref>]. Gene sequencing and pathogenic variant scanning methods may detect such deletions in males (<xref ref-type="table" rid="mtm.T.summary_of_molecular_genetic_testi">Table 1</xref>, footnote 4); however, these methods cannot detect deletions in female carriers. Methods such as real-time quantitative PCR or targeted array CGH can be used to detect specific deletions in carrier females or in rare affected females once the deletion is identified in an affected male relative.</p>
              </list-item>
              <list-item>
                <p>The occurrence of at least one deep intronic pathogenic variant detected by cDNA and protein analysis has been described [<xref ref-type="bibr" rid="mtm.REF.tosch.2010.375">Tosch et al 2010</xref>]. Complementary DNA and protein analysis can be performed to detect intronic and non-coding variants.</p>
              </list-item>
            </list>
            <table-wrap id="mtm.T.summary_of_molecular_genetic_testi" position="anchor" orientation="portrait">
              <label>Table 1. </label>
              <caption>
                <p>Summary of Molecular Genetic Testing Used in X-Linked Centronuclear Myopathy</p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th id="hd_h_mtm.T.summary_of_molecular_genetic_testi_1_1_1_1" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_mtm.T.summary_of_molecular_genetic_testi_1_1_1_1">Gene&#x000a0;<sup>1</sup></th>
                    <th id="hd_h_mtm.T.summary_of_molecular_genetic_testi_1_1_1_2" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_mtm.T.summary_of_molecular_genetic_testi_1_1_1_2">Test Method</th>
                    <th id="hd_h_mtm.T.summary_of_molecular_genetic_testi_1_1_1_3" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_mtm.T.summary_of_molecular_genetic_testi_1_1_1_3">Allelic Variants Detected&#x000a0;<sup>2</sup></th>
                    <th id="hd_h_mtm.T.summary_of_molecular_genetic_testi_1_1_1_4" valign="middle" colspan="2" align="left" scope="colgroup" rowspan="1">Variant Detection Frequency by Test Method&#x000a0;<sup>3</sup></th>
                  </tr>
                  <tr>
                    <th headers="hd_h_mtm.T.summary_of_molecular_genetic_testi_1_1_1_4" id="hd_h_mtm.T.summary_of_molecular_genetic_testi_1_1_2_1" valign="middle" colspan="1" align="left" scope="colgroup" rowspan="1">Males</th>
                    <th headers="hd_h_mtm.T.summary_of_molecular_genetic_testi_1_1_1_4" id="hd_h_mtm.T.summary_of_molecular_genetic_testi_1_1_2_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Heterozygous Females</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td headers="hd_h_mtm.T.summary_of_molecular_genetic_testi_1_1_1_1" rowspan="2" valign="middle" align="left" scope="row" colspan="1">
                      <italic toggle="yes">MTM1</italic>
                    </td>
                    <td headers="hd_h_mtm.T.summary_of_molecular_genetic_testi_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>4</sup> / scanning for pathogenic variants&#x000a0;<sup>5</sup></td>
                    <td headers="hd_h_mtm.T.summary_of_molecular_genetic_testi_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Sequence variants</td>
                    <td headers="hd_h_mtm.T.summary_of_molecular_genetic_testi_1_1_1_4 hd_h_mtm.T.summary_of_molecular_genetic_testi_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">60%-98%&#x000a0;<sup>6,&#x000a0;7</sup></td>
                    <td headers="hd_h_mtm.T.summary_of_molecular_genetic_testi_1_1_1_4 hd_h_mtm.T.summary_of_molecular_genetic_testi_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">53%-98%&#x000a0;<sup>8</sup></td>
                  </tr>
                  <tr>
                    <td headers="hd_h_mtm.T.summary_of_molecular_genetic_testi_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Deletion/duplication analysis&#x000a0;<sup>9</sup></td>
                    <td headers="hd_h_mtm.T.summary_of_molecular_genetic_testi_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">(Multi)exon or whole-gene deletion/duplication</td>
                    <td headers="hd_h_mtm.T.summary_of_molecular_genetic_testi_1_1_1_4 hd_h_mtm.T.summary_of_molecular_genetic_testi_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">7%</td>
                    <td headers="hd_h_mtm.T.summary_of_molecular_genetic_testi_1_1_1_4 hd_h_mtm.T.summary_of_molecular_genetic_testi_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">7%</td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn id="mtm.TF.1.1">
                  <label>1. </label>
                  <p>See <related-object source-id="gene" document-id="mtm" object-id="mtm.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein.</p>
                </fn>
                <fn id="mtm.TF.1.2">
                  <label>2. </label>
                  <p>See <xref ref-type="sec" rid="mtm.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants.</p>
                </fn>
                <fn id="mtm.TF.1.3">
                  <label>3. </label>
                  <p>The ability of the test method used to detect a variant that is present in the indicated gene</p>
                </fn>
                <fn id="mtm.TF.1.4">
                  <label>4. </label>
                  <p>Examples of pathogenic variants detected by sequence analysis may include small intragenic deletions/insertions and missense, nonsense, and splice site variants; typically, exon or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
                </fn>
                <fn id="mtm.TF.1.5">
                  <label>5. </label>
                  <p>Sequence analysis and scanning of the entire gene for pathogenic variants can have similar variant detection frequencies; however, variant detection frequencies for pathogenic variant scanning may differ considerably among laboratories depending on the specific protocol used.</p>
                </fn>
                <fn id="mtm.TF.1.6">
                  <label>6. </label>
                  <p>Lack of amplification by PCRs prior to sequence analysis can suggest a putative deletion of one or more exons or the entire X-linked gene in a male; confirmation may require additional testing by deletion/duplication analysis.</p>
                </fn>
                <fn id="mtm.TF.1.7">
                  <label>7. </label>
                  <p>Includes the variant detection frequency using deletion/duplication analysis</p>
                </fn>
                <fn id="mtm.TF.1.8">
                  <label>8. </label>
                  <p>Sequence analysis of genomic DNA cannot detect deletion of one or more exons or the entire X-linked gene in a heterozygous female.</p>
                </fn>
                <fn id="mtm.TF.1.9">
                  <label>9. </label>
                  <p>Testing that identifies deletions/duplications not readily detectable by sequence analysis of the coding and flanking intronic regions of genomic DNA; a variety of methods including quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), or targeted array GH (gene/segment-specific) may be used. A full array GH analysis that detects deletions/duplications across the genome may also include this gene/segment.</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
            <p>If no pathogenic variant is found in a male proband, the diagnosis of XLCNM cannot be completely excluded. The failure to detect pathogenic variants in approximately 10%-40% of males in whom the diagnosis of XLCNM was suspected, including several males with pedigrees consistent with an X-linked pattern of inheritance [<xref ref-type="bibr" rid="mtm.REF.tanner.1999b.41">Tanner et al 1999b</xref>, <xref ref-type="bibr" rid="mtm.REF.copley.2002.256">Copley et al 2002</xref>, <xref ref-type="bibr" rid="mtm.REF.herman.2002.114">Herman et al 2002</xref>, <xref ref-type="bibr" rid="mtm.REF.bertini.2004.387">Bertini et al 2004</xref>, <xref ref-type="bibr" rid="mtm.REF.tsai.2005.245">Tsai et al 2005</xref>], could reflect one of the following:</p>
            <list list-type="bullet">
              <list-item>
                <p>Misdiagnosis</p>
              </list-item>
              <list-item>
                <p>Autosomal dominant or autosomal recessive centronuclear myopathy</p>
              </list-item>
              <list-item>
                <p>Presence of pathogenic variants in <italic toggle="yes">MTM1</italic> regulatory or intronic sequences that may have been missed by the variant detection protocols used</p>
              </list-item>
            </list>
            <p><bold>Linkage analysis for families in which no <italic toggle="yes">MTM1</italic> pathogenic variant has been identified.</bold> Benign allelic variants within the gene have been identified (see <xref ref-type="sec" rid="mtm.Molecular_Genetics">Molecular Genetics</xref>) and can be used for linkage analysis; however, linkage analysis is not the method of choice for genetic testing and should be undertaken with extreme caution for the following reasons:</p>
            <list list-type="bullet">
              <list-item>
                <p>An autosomal form of myotubular myopathy could be present.</p>
              </list-item>
              <list-item>
                <p>Even in families with an X-linked pattern of inheritance, it is remotely possible that mutation in another X-linked gene is causative.</p>
              </list-item>
            </list>
          </sec>
        </sec>
        <sec id="mtm.Testing_Strategy">
          <title>Testing Strategy</title>
          <p><bold>To confirm/establish the diagnosis in a male proband.</bold> In males with a &#x0201c;typical&#x0201d; clinical presentation (neonatal hypotonia and weakness), the diagnosis of XLCNM relies on:</p>
          <list list-type="bullet">
            <list-item>
              <p>The observation of characteristic histopathologic changes on muscle biopsy, followed by</p>
            </list-item>
            <list-item>
              <p>Genetic testing of <italic toggle="yes">MTM1</italic>.</p>
            </list-item>
          </list>
          <p>If <italic toggle="yes">MTM1</italic> sequencing is unrevealing, genetic studies for the other known causes of CNM should be undertaken (see <xref ref-type="sec" rid="mtm.Differential_Diagnosis">Differential Diagnosis</xref>).</p>
          <p>If additional more specific clinical characteristics exist (e.g., large growth parameters and restricted eye movements), molecular genetic testing may precede biopsy, especially if family history is consistent with X-linked inheritance.</p>
          <p>In infants with a less specific presentation, in older males with mild weakness, and in those individuals without a clear family history, muscle biopsy is considered the test of choice, with molecular genetic testing to follow if the typical biopsy features of centronuclear myopathy are observed.</p>
          <p><bold>Carrier testing for at-risk relatives</bold> requires prior identification of the pathogenic variant in the family.</p>
          <p>
            <bold>Carrier females</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Carrier testing for a large deletion of <italic toggle="yes">MTM1</italic> requires deletion/duplication analysis (e.g., real-time quantitative PCR or Southern blot analysis).</p>
            </list-item>
            <list-item>
              <p>In families in which the proband is deceased and no DNA from an affected male is available for molecular genetic testing, the mother of the deceased proband can be tested to try to identify the family-specific pathogenic variant and, hence, to determine her carrier status. Because of the high probability that the mother of an affected male is a carrier (see <xref ref-type="sec" rid="mtm.Risk_to_Family_Members">Risk to Family Members</xref>), the likelihood of identifying an <italic toggle="yes">MTM1</italic> pathogenic variant is high. However, if no pathogenic variant is identified by sequence analysis and deletion/duplication analysis, the presence of either germline mosaicism for an <italic toggle="yes">MTM1</italic> pathogenic variant or a variant in a non-coding region remain possibilities. Thus, if an <italic toggle="yes">MTM1</italic> pathogenic variant is not identified in the mother, prenatal diagnosis by full gene sequencing of <italic toggle="yes">MTM1</italic> in a male fetus may still be considered.</p>
            </list-item>
          </list>
          <p>Note: (1) Carriers are heterozygotes for this X-linked disorder and in rare instances may develop clinical findings related to the disorder. (2) Identification of female carriers requires either (a) prior identification of the pathogenic variant in the family or, if an affected male is not available for testing, (b) molecular genetic testing usually first by sequence analysis, and then (if no pathogenic variant is identified) by methods to detect deletions/duplications.</p>
          <p><bold>Prenatal diagnosis and preimplantation genetic diagnosis (PGD)</bold> for at-risk pregnancies require prior identification of the pathogenic variant in the family.</p>
        </sec>
      </sec>
      <sec id="mtm.Clinical_Characteristics">
        <title>Clinical Characteristics</title>
        <sec id="mtm.Clinical_Description">
          <title>Clinical Description</title>
          <p>Two large published clinical series have described, respectively, 37 and 55 males with XLCNM [<xref ref-type="bibr" rid="mtm.REF.wallgrenpettersson.1995.673">Wallgren-Pettersson et al 1995</xref>, <xref ref-type="bibr" rid="mtm.REF.herman.1999.206">Herman et al 1999</xref>]. In the latter series, the X-linked form of CNM was confirmed in all of the reported individuals through direct molecular genetic testing of <italic toggle="yes">MTM1</italic>.</p>
          <p>Following isolation of <italic toggle="yes">MTM1</italic> in 1996, <xref ref-type="bibr" rid="mtm.REF.herman.1999.206">Herman et al [1999]</xref> described a clinical classification for the broader phenotype. Individuals with <italic toggle="yes">MTM1</italic> pathogenic variants were classified as having one of the following:</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Severe (classic) XLCNM.</bold> Characteristic facies, chronic ventilator dependence, grossly delayed motor milestones, non-ambulatory, high incidence of death in infancy</p>
            </list-item>
            <list-item>
              <p><bold>Moderate XLCNM.</bold> Less severely delayed motor milestones than in the severe form, prolonged periods of decreased ventilatory support</p>
            </list-item>
            <list-item>
              <p><bold>Mild XLCNM.</bold> Ambulatory with minimally delayed motor milestones, chronic ventilatory support not required beyond the newborn period, potential absence of typical myopathic facies</p>
            </list-item>
          </list>
          <p>Since publication of the phenotypic classification by <xref ref-type="bibr" rid="mtm.REF.herman.1999.206">Herman et al [1999]</xref>, an adult-onset form has been reported in two males with <italic toggle="yes">MTM1</italic> pathogenic variants who had no clinical manifestations in infancy but developed a slowly progressive myopathy in adulthood [<xref ref-type="bibr" rid="mtm.REF.biancalana.2003.135">Biancalana et al 2003</xref>, <xref ref-type="bibr" rid="mtm.REF.yu.2003.148">Yu et al 2003</xref>, <xref ref-type="bibr" rid="mtm.REF.hoffjan.2006.749">Hoffjan et al 2006</xref>]. This phenotype is likely to be very rare.</p>
          <sec id="mtm.SevereClassic_XLCNM">
            <title>Severe/Classic XLCNM</title>
            <p>In males with the classic, severe neonatal presentation, polyhydramnios with decreased fetal movement is often present prenatally. Typically, however, the disease presents with hypotonia, extremity weakness, and respiratory distress during the newborn period. Hypotonia and weakness in the neonatal period, while not specific to XLCNM, appear to be universal findings. In addition, in the US series of <xref ref-type="bibr" rid="mtm.REF.herman.1999.206">Herman et al [1999]</xref>, 80% of affected newborns required endotracheal intubation and ventilatory support at birth. Infants with classic XLCNM have prolonged ventilator dependence with risk of intercurrent respiratory infection, hypoventilation, and hypoxia.</p>
            <p>Affected infants often have typical myopathic facies with dolicocephaly, high forehead, long face with midface hypoplasia, and narrow high-arched palate with subsequent severe malocclusion. Ophthalmoparesis is also frequently observed. Additional features in the US series included length greater than the 90th centile with a proportionately lower weight (60% of infants), long fingers and/toes (43%), cryptorchidism (&#x0003e;50%), contractures including clubfeet (30%), and areflexia (60%).</p>
            <p>Many infants with XLCNM severe/classic form succumb to complications of the disorder. For surviving infants in the US, the average length of initial hospitalization is approximately 90 days. Most surviving males in the United States are discharged home on 24-hour ventilatory support via tracheostomy and gastrostomy (G-tube) feedings.</p>
            <p>The muscle disease is not thought to be progressive, though this has not been systematically examined.</p>
            <p>Although the prognosis for this disorder had long been considered grave, 64% of males in the US series survived to at least age one year. Approximately 60% of this group required ventilatory support 24 hrs/day, 20% required support for eight to 18 hrs/day, and 20% did not require or were not receiving any ventilatory support. Long-term survival rates in Europe have been lower and could reflect differences in management and supportive care. The increase in survival rate seen in the US series is thought to be reflective of intensive medical intervention, without which the majority of affected individuals would not survive [<xref ref-type="bibr" rid="mtm.REF.mcentagart.2002.939">McEntagart et al 2002</xref>]. Children who survive the first year of life continue to have significant morbidity and early mortality. The cause of death is usually related to respiratory failure.</p>
            <p><bold>Growth and development.</bold> Despite chronic illness and prolonged ventilator dependence, many individuals with XLCNM have linear growth above the 50th centile, with some individuals in the US series achieving greater than the 90th centile for height. Advanced bone age and/or premature adrenarche have been documented in several young males, suggesting some disturbance of endocrine regulation; however, endocrinologic studies performed on several individuals have been normal. Puberty has occurred normally in the few males who have reached adulthood.</p>
            <p>In the absence of significant hypoxic episodes, cognitive development is normal in the majority of individuals. Rare individuals with central nervous system complications have been reported [<xref ref-type="bibr" rid="mtm.REF.mccrea.2009.483">McCrea et al 2009</xref>].</p>
            <p><bold>Other findings.</bold> Additional features of the underlying myopathy are ophthalmoplegia, ptosis, and severe myopia. Dental malocclusion (requiring orthodontic care) may occur. Scoliosis often develops in later childhood and may require surgical intervention. Scoliosis can exacerbate respiratory insufficiency, in some cases causing ventilator-independent males to become ventilator dependent again as it progresses. Additional orthopedic manifestations include hip dysplasia and, as observed in a small case series, long bone fractures [<xref ref-type="bibr" rid="mtm.REF.cahill.2007.98">Cahill et al 2007</xref>].</p>
            <p><bold>Medical problems.</bold> With more aggressive supportive care and longer survival of some individuals with XLCNM, medical problems unrelated to the muscle disorder, including pyloric stenosis, a mild form of spherocytosis, gallstones, kidney stones or nephrocalcinosis, a vitamin K-responsive bleeding diathesis, and liver dysfunction manifested by pruritus and elevated serum transaminases, have occurred [<xref ref-type="bibr" rid="mtm.REF.herman.1999.206">Herman et al 1999</xref>].</p>
            <p>Several individuals died following prolonged liver hemorrhage or hemorrhage into the peritoneal cavity. Three individuals had peliosis hepatis, a rare vascular lesion characterized by the presence of multiple blood-filled cysts within the liver [<xref ref-type="bibr" rid="mtm.REF.herman.1999.206">Herman et al 1999</xref>, <xref ref-type="bibr" rid="mtm.REF.wang.2001.1456">Wang et al 2001</xref>]. Several additional boys with XLCNM have had liver dysfunction, peliosis, or hemorrhage into the peritoneum [Herman, personal observation]. The pathogenic mechanisms for these complications are not understood, but their lack of occurrence in other congenital myopathies and similarly severe neuromuscular disorders (including especially spinal muscular atrophy) strongly suggest that they are related to abnormal function of or absence of myotubularin. Those at increased risk for these complications cannot be identified by clinical features or pathogenic variant at the present time. In at least one affected individual, findings of peliosis detected on ultrasound examination subsequently resolved. Several families have also reported this feature in their affected children [personal observation].</p>
          </sec>
          <sec id="mtm.Mild_and_Moderate_XLCNM">
            <title>Mild and Moderate XLCNM</title>
            <p>At least three reports of multigenerational families with <italic toggle="yes">MTM1</italic> pathogenic variants and a much milder phenotype have been described [<xref ref-type="bibr" rid="mtm.REF.barth.1998.49">Barth &#x00026; Dubowitz 1998</xref>, <xref ref-type="bibr" rid="mtm.REF.biancalana.2003.135">Biancalana et al 2003</xref>, <xref ref-type="bibr" rid="mtm.REF.yu.2003.148">Yu et al 2003</xref>, <xref ref-type="bibr" rid="mtm.REF.hoffjan.2006.749">Hoffjan et al 2006</xref>].</p>
            <p>Males with moderate or even mild disease are at increased risk for respiratory decompensation with intercurrent illness and may require transient or increased ventilatory support. They are also at risk for some of the same medical complications (including peliosis hepatis) as those with severe XLCNM [<xref ref-type="bibr" rid="mtm.REF.herman.1999.206">Herman et al 1999</xref>].</p>
            <p>The oldest known individuals with pathogenic variants in <italic toggle="yes">MTM1</italic> are in their sixties [<xref ref-type="bibr" rid="mtm.REF.biancalana.2003.135">Biancalana et al 2003</xref>, <xref ref-type="bibr" rid="mtm.REF.hoffjan.2006.749">Hoffjan et al 2006</xref>]. The first is a 67-year-old male who did not have significant respiratory problems or hypotonia in infancy and who first walked at age 18 months [<xref ref-type="bibr" rid="mtm.REF.biancalana.2003.135">Biancalana et al 2003</xref>]. The first symptom was diffuse muscle weakness at age 20 years, resulting in walking difficulties and scapular winging. He needed a tracheotomy to manage bronchopneumonia at age 55 years and now requires respiratory support during the night. He is reported to have a similarly affected 48-year-old brother and two grandsons, ages five and 13 years respectively, both of whom demonstrated hypotonia, respiratory difficulties at birth, some delay in motor development, and muscle weakness; however, both are able to walk and attend regular school.</p>
            <p>The second is a 68-year-old male who reported no significant delay in his early motor development and had mild hypotonia during childhood. At about age 52 years he developed slowly increasing muscular weakness in his arms and had difficulties climbing stairs. At age 65 years he suffered from a severe pneumonia that was accompanied by an acute exacerbation of muscle weakness. A muscle biopsy at that time demonstrated typical features of centronuclear myopathy. Clinical examination at age 68 years revealed a slightly myopathic facial expression, mild paresis of horizontal eye movements, a high palatal arch, mild scapular winging and prominent wasting and weakness of proximal muscles. This individual was diagnosed after his grandson, who had a severe phenotype including muscular weakness and respiratory problems at birth, was determined to have XLCNM.</p>
            <p><xref ref-type="bibr" rid="mtm.REF.yu.2003.148">Yu et al [2003]</xref> described two males with a pathogenic variant in <italic toggle="yes">MTM1</italic>, age 55 and 30 years, both of whom live independently. The 30-year-old developed some muscle weakness later in life and had decreased muscle bulk that was improved by diet and weight-lifting exercises.</p>
            <p><bold>Carrier females.</bold> Female carriers of XLCNM are generally asymptomatic, although rare manifesting heterozygotes have been described [<xref ref-type="bibr" rid="mtm.REF.tanner.1999a.249">Tanner et al 1999a</xref>, <xref ref-type="bibr" rid="mtm.REF.tanner.1999b.41">Tanner et al 1999b</xref>, <xref ref-type="bibr" rid="mtm.REF.hammans.2000.133">Hammans et al 2000</xref>, <xref ref-type="bibr" rid="mtm.REF.wallgrenpettersson.2000.525">Wallgren-Pettersson 2000</xref>, <xref ref-type="bibr" rid="mtm.REF.sutton.2001.900">Sutton et al 2001</xref>, <xref ref-type="bibr" rid="mtm.REF.jungbluth.2003.55">Jungbluth et al 2003</xref>, <xref ref-type="bibr" rid="mtm.REF.schara.2003.1363">Schara et al 2003</xref>, <xref ref-type="bibr" rid="mtm.REF.grogan.2005.1638">Grogan et al 2005</xref>, <xref ref-type="bibr" rid="mtm.REF.p_nissonbesnier.2007.180">P&#x000e9;nisson-Besnier et al 2007</xref>]. Manifesting female carriers typically have skewed X-chromosome inactivation [<xref ref-type="bibr" rid="mtm.REF.kristiansen.2003.468">Kristiansen et al 2003</xref>].</p>
          </sec>
        </sec>
        <sec id="mtm.GenotypePhenotype_Correlations">
          <title>Genotype-Phenotype Correlations</title>
          <p>Genotype-phenotype correlations have been observed in XLCNM, but no definitive pattern exists and exceptions have been reported. Phenotypic variability has been observed in family members with the same pathogenic variant [<xref ref-type="bibr" rid="mtm.REF.barth.1998.49">Barth &#x00026; Dubowitz 1998</xref>, <xref ref-type="bibr" rid="mtm.REF.laporte.2000.393">Laporte et al 2000</xref>] and in unrelated individuals with recurrent pathogenic variants [<xref ref-type="bibr" rid="mtm.REF.mcentagart.2002.939">McEntagart et al 2002</xref>]. General genotype-phenotype guidelines have emerged nonetheless, but caution is warranted in using genetic testing to predict an individual&#x02019;s prognosis.</p>
          <p><bold>Practically all truncating (nonsense and frameshift) variants and variants that alter splice sites</bold> are associated with severe disease. However, exceptions occur; for example:</p>
          <list list-type="bullet">
            <list-item>
              <p>Recurrent nonsense pathogenic variants (e.g., <xref ref-type="table" rid="mtm.T.selected_mtm1_allelic_variants">p.Arg37Ter</xref> and <xref ref-type="table" rid="mtm.T.selected_mtm1_allelic_variants">p.Glu48Ter</xref>) most often associated with the severe phenotype have been described in individuals with the moderate phenotype [<xref ref-type="bibr" rid="mtm.REF.laporte.1997.1505">Laporte et al 1997</xref>, <xref ref-type="bibr" rid="mtm.REF.bujbello.1999.320">Buj-Bello et al 1999</xref>, <xref ref-type="bibr" rid="mtm.REF.herman.1999.206">Herman et al 1999</xref>, <xref ref-type="bibr" rid="mtm.REF.tanner.1999b.41">Tanner et al 1999b</xref>, <xref ref-type="bibr" rid="mtm.REF.laporte.2000.393">Laporte et al 2000</xref>, <xref ref-type="bibr" rid="mtm.REF.herman.2002.114">Herman et al 2002</xref>, <xref ref-type="bibr" rid="mtm.REF.mcentagart.2002.939">McEntagart et al 2002</xref>].</p>
            </list-item>
            <list-item>
              <p>Truncating and splicing variants that affect the 3' end of <italic toggle="yes">MTM1</italic>, which encodes parts of myotubularin that are distal to the phosphatase active site and SET-interacting domain, may also be associated with the moderate or mild phenotypes [<xref ref-type="bibr" rid="mtm.REF.herman.1999.206">Herman et al 1999</xref>, <xref ref-type="bibr" rid="mtm.REF.laporte.2000.393">Laporte et al 2000</xref>].</p>
            </list-item>
          </list>
          <p><bold>Splicing variants</bold> that do not affect the canonic splice donor or acceptor sites and that may result in the production of some normal <italic toggle="yes">MTM1</italic> transcript have also been observed in individuals with a milder phenotype [<xref ref-type="bibr" rid="mtm.REF.tsai.2005.245">Tsai et al 2005</xref>].</p>
          <p><bold>Deletions</bold> have been described in some males with XLCNM who also have abnormal genitalia. These cases likely represent a contiguous gene deletion syndrome in which a gene critical to male genital development was co-deleted with <italic toggle="yes">MTM1</italic> [<xref ref-type="bibr" rid="mtm.REF.hu.1996.139">Hu et al 1996</xref>, <xref ref-type="bibr" rid="mtm.REF.bartsch.1999.310">Bartsch et al 1999</xref>] (see <xref ref-type="sec" rid="mtm.Genetically_Related_Allelic_Disorder">Genetically Related Disorders</xref>).</p>
          <p>
            <bold>Missense variants</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Pathogenic missense variants that occur in the phosphatase active site or the SET-interacting domain of myotubularin are associated with a severe phenotype [<xref ref-type="bibr" rid="mtm.REF.mcentagart.2002.939">McEntagart et al 2002</xref>].</p>
            </list-item>
            <list-item>
              <p>Pathogenic missense variants that alter amino acids conserved across species or in human myotubularin-related genes are associated with a severe phenotype [<xref ref-type="bibr" rid="mtm.REF.laporte.2001a.221">Laporte et al 2001a</xref>].</p>
            </list-item>
            <list-item>
              <p>Pathogenic missense variants that avoid the phosphatase active site or the SET-interacting domain of myotubularin tend to be associated with less severe phenotype [<xref ref-type="bibr" rid="mtm.REF.herman.1999.206">Herman et al 1999</xref>, <xref ref-type="bibr" rid="mtm.REF.laporte.2000.393">Laporte et al 2000</xref>, <xref ref-type="bibr" rid="mtm.REF.herman.2002.114">Herman et al 2002</xref>, <xref ref-type="bibr" rid="mtm.REF.mcentagart.2002.939">McEntagart et al 2002</xref>].</p>
            </list-item>
            <list-item>
              <p>Wide phenotypic variation has been observed for some pathogenic missense variants (e.g., <xref ref-type="table" rid="mtm.T.selected_mtm1_allelic_variants">p.Ile225Thr</xref>, <xref ref-type="table" rid="mtm.T.selected_mtm1_allelic_variants">p.Arg241Cys</xref>, <xref ref-type="table" rid="mtm.T.selected_mtm1_allelic_variants">p.Arg421Gln</xref>) for which severely and mildly affected individuals are known, and phenotypic variability has even been described within families [<xref ref-type="bibr" rid="mtm.REF.tanner.1999b.41">Tanner et al 1999b</xref>, <xref ref-type="bibr" rid="mtm.REF.bujbello.1999.320">Buj-Bello et al 1999</xref>, <xref ref-type="bibr" rid="mtm.REF.de_gouyon.1997.1499">de Gouyon et al 1997</xref>].</p>
            </list-item>
            <list-item>
              <p>Additional pathogenic missense variants that have been found in individuals with both severe and mild phenotypes include <xref ref-type="table" rid="mtm.T.selected_mtm1_allelic_variants">p.Pro205Leu</xref> and <xref ref-type="table" rid="mtm.T.selected_mtm1_allelic_variants">p.Arg69Cys</xref> [<xref ref-type="bibr" rid="mtm.REF.de_gouyon.1997.1499">de Gouyon et al 1997</xref>, <xref ref-type="bibr" rid="mtm.REF.laporte.1997.1505">Laporte et al 1997</xref>, <xref ref-type="bibr" rid="mtm.REF.herman.2002.114">Herman et al 2002</xref>, <xref ref-type="bibr" rid="mtm.REF.cox.2005.441">Cox et al 2005</xref>, <xref ref-type="bibr" rid="mtm.REF.tsai.2005.245">Tsai et al 2005</xref>].</p>
            </list-item>
          </list>
          <p><bold>Seven recurrent variants</bold> account for approximately 25% of all <italic toggle="yes">MTM1</italic> pathogenic variants [<xref ref-type="bibr" rid="mtm.REF.tanner.1999b.41">Tanner et al 1999b</xref>, <xref ref-type="bibr" rid="mtm.REF.laporte.2000.393">Laporte et al 2000</xref>, <xref ref-type="bibr" rid="mtm.REF.herman.2002.114">Herman et al 2002</xref>, <xref ref-type="bibr" rid="mtm.REF.mcentagart.2002.939">McEntagart et al 2002</xref>, <xref ref-type="bibr" rid="mtm.REF.bertini.2004.387">Bertini et al 2004</xref>, <xref ref-type="bibr" rid="mtm.REF.tsai.2005.245">Tsai et al 2005</xref>]:</p>
          <list list-type="bullet">
            <list-item>
              <p>The most common is the <xref ref-type="table" rid="mtm.T.selected_mtm1_allelic_variants">c.1261-10A&#x0003e;G</xref> variant in intron 11, which produces an in-frame insertion of three amino acids associated with the severe phenotype in all cases. Confirmation of this pathogenic variant has been performed by RT-PCR in lymphoblasts [<xref ref-type="bibr" rid="mtm.REF.de_gouyon.1997.1499">de Gouyon et al 1997</xref>] and muscle tissue [<xref ref-type="bibr" rid="mtm.REF.nishino.1998.453">Nishino et al 1998</xref>, <xref ref-type="bibr" rid="mtm.REF.tanner.1998.62">Tanner et al 1998</xref>]. The high rate of occurrence of this pathogenic variant remains unexplained.</p>
            </list-item>
            <list-item>
              <p>The variants <xref ref-type="table" rid="mtm.T.selected_mtm1_allelic_variants">c.141-144delAGAA</xref>, <xref ref-type="table" rid="mtm.T.selected_mtm1_allelic_variants">p.Arg37Ter</xref>, <xref ref-type="table" rid="mtm.T.selected_mtm1_allelic_variants">p.Pro205Leu</xref>, <xref ref-type="table" rid="mtm.T.selected_mtm1_allelic_variants">p.Arg421Gln</xref>, and <xref ref-type="table" rid="mtm.T.selected_mtm1_allelic_variants">p.Arg421Ter</xref> are mainly associated with the severe form of the disease; the variant <xref ref-type="table" rid="mtm.T.selected_mtm1_allelic_variants">p.Arg421Cys</xref> is associated with a mild or variable phenotype [<xref ref-type="bibr" rid="mtm.REF.bertini.2004.387">Bertini et al 2004</xref>].</p>
            </list-item>
          </list>
        </sec>
        <sec id="mtm.Penetrance">
          <title>Penetrance</title>
          <p>Penetrance is thought to be 100% in affected males. To date all males with a pathogenic variant in <italic toggle="yes">MTM1</italic> have shown findings of the disease, although disease severity can range from mild to severe.</p>
          <p>Carrier females are generally asymptomatic; rare manifesting heterozygotes have been described [<xref ref-type="bibr" rid="mtm.REF.tanner.1999a.249">Tanner et al 1999a</xref>, <xref ref-type="bibr" rid="mtm.REF.tanner.1999b.41">Tanner et al 1999b</xref>, <xref ref-type="bibr" rid="mtm.REF.hammans.2000.133">Hammans et al 2000</xref>, <xref ref-type="bibr" rid="mtm.REF.wallgrenpettersson.2000.525">Wallgren-Pettersson 2000</xref>, <xref ref-type="bibr" rid="mtm.REF.sutton.2001.900">Sutton et al 2001</xref>, <xref ref-type="bibr" rid="mtm.REF.jungbluth.2003.55">Jungbluth et al 2003</xref>, <xref ref-type="bibr" rid="mtm.REF.schara.2003.1363">Schara et al 2003</xref>, <xref ref-type="bibr" rid="mtm.REF.grogan.2005.1638">Grogan et al 2005</xref>, <xref ref-type="bibr" rid="mtm.REF.p_nissonbesnier.2007.180">P&#x000e9;nisson-Besnier et al 2007</xref>]. Manifesting female carriers typically have skewed X-chromosome inactivation [<xref ref-type="bibr" rid="mtm.REF.kristiansen.2003.468">Kristiansen et al 2003</xref>].</p>
        </sec>
        <sec id="mtm.Anticipation">
          <title>Anticipation</title>
          <p>XLCNM is generally not associated with anticipation. However, in two families the maternal grandfather had adult-onset disorder of very mild disease, whereas their affected grandsons had severe hypotonia and respiratory insufficiency at birth requiring ventilatory assistance [<xref ref-type="bibr" rid="mtm.REF.biancalana.2003.135">Biancalana et al 2003</xref>, <xref ref-type="bibr" rid="mtm.REF.hoffjan.2006.749">Hoffjan et al 2006</xref>].</p>
        </sec>
        <sec id="mtm.Nomenclature">
          <title>Nomenclature</title>
          <p>Myotubular myopathy (or X-linked centronuclear myopathy [XLCNM]) is considered a subtype of centronuclear myopathy based on the centrally located nuclei of muscle fibers on histologic examination. Autosomal dominant and autosomal recessive centronuclear myopathy should not be referred to as myotubular myopathy.</p>
          <p>Males with XLCNM with identifiable pathogenic variants in <italic toggle="yes">MTM1</italic> are said to have myotubular myopathy (MTM). This term should only be used to refer to individuals with documented or presumed <italic toggle="yes">MTM1</italic> pathogenic variants.</p>
        </sec>
        <sec id="mtm.Prevalence">
          <title>Prevalence</title>
          <p>It has been estimated that XLCNM affects approximately one in 50,000 newborn males [<xref ref-type="bibr" rid="mtm.REF.laporte.2001a.221">Laporte et al 2001a</xref>]; careful, large studies attempting complete ascertainment have not been published.</p>
        </sec>
      </sec>
      <sec id="mtm.Genetically_Related_Allelic_Disorder">
        <title>Genetically Related (Allelic) Disorders</title>
        <p>No other phenotype is known to be associated with pathogenic variants in <italic toggle="yes">MTM1</italic>.</p>
        <p><bold>Contiguous gene deletion.</bold> Deletions of the entire <italic toggle="yes">MTM1</italic> gene were initially identified in two males [<xref ref-type="bibr" rid="mtm.REF.hu.1996.139">Hu et al 1996</xref>] and one female [<xref ref-type="bibr" rid="mtm.REF.dahl.1995.1108">Dahl et al 1995</xref>] who had clinical features in addition to those seen in XLCNM as a result of deletion of adjacent X-linked genes:</p>
        <list list-type="bullet">
          <list-item>
            <p>One of the two males had ambiguous genitalia, the other perineoscrotal hypospadias [<xref ref-type="bibr" rid="mtm.REF.hu.1996.139">Hu et al 1996</xref>]. They had overlapping submicroscopic deletions defining a critical region of approximately 430 kb that was expected to contain <italic toggle="yes">MTM1</italic> as well as a novel gene implicated in male sexual development. The latter gene was subsequently identified [<xref ref-type="bibr" rid="mtm.REF.laporte.1997.1505">Laporte et al 1997</xref>] and lies 80 kb centromeric to <italic toggle="yes">MTM1</italic>. Three of four subsequently described males with large deletions involving all of <italic toggle="yes">MTM1</italic> and flanking genes had hypogenitalism [<xref ref-type="bibr" rid="mtm.REF.bartsch.1999.310">Bartsch et al 1999</xref>, <xref ref-type="bibr" rid="mtm.REF.biancalana.2003.135">Biancalana et al 2003</xref>, <xref ref-type="bibr" rid="mtm.REF.tsai.2005.245">Tsai et al 2005</xref>].</p>
          </list-item>
          <list-item>
            <p>The female reported by <xref ref-type="bibr" rid="mtm.REF.dahl.1995.1108">Dahl et al [1995]</xref> had a cytogenetically visible deletion that also included the loci for <related-object link-type="booklink" source-id="gene" document-id="fragilex" document-type="chapter">fragile X syndrome</related-object> and <related-object link-type="booklink" source-id="gene" document-id="hunter" document-type="chapter">Hunter syndrome</related-object>. She had a moderate myopathy as well as intellectual disability. Her symptoms were presumed to result from preferential inactivation of her normal X chromosome, as the deleted X chromosome was active in approximately 80% of her leukocytes.</p>
          </list-item>
        </list>
      </sec>
      <sec id="mtm.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p><bold>Congenital</bold>
<related-object link-type="booklink" source-id="gene" document-id="myotonic-d" document-type="chapter"><bold>myotonic dystrophy type 1</bold></related-object>
<bold>(DM1)</bold> is the most likely differential diagnosis for a male with severe XLCNM. Like XLCNM, congenital DM1 may present in utero with polyhydramnios and with weak or infrequent fetal movements. At birth, affected infants are weak, hypotonic, have a myopathic facies, and often require ventilatory support. Hypotonia and myopathy gradually improve, though neonatal mortality as a result of respiratory failure occurs in a significant minority of cases. Children with congenital DM1 may stabilize for many years, but continue to have significant co-morbidities including a high incidence of intellectual disability (50%-60%). Muscle biopsies from infants with congenital DM1 may be indistinguishable from those in infants with XLCNM [<xref ref-type="bibr" rid="mtm.REF.dubowitz.2006">Dubowitz &#x00026; Sewry 2006</xref>]. The diagnosis of congenital DM1 is confirmed by identification of more than 1000 CTG repeats in <italic toggle="yes">DMPK</italic>. The CTG expansion is often more than 2000 repeats in length and, in the severe congenital cases, virtually always inherited from the mother, who may or may not be symptomatic.</p>
        <p><bold>Other centronuclear myopathies.</bold> Myotubular myopathy is the most common form of a broader group of myopathies termed centronuclear myopathies (CNMs) [<xref ref-type="bibr" rid="mtm.REF.pierson.2005.555">Pierson et al 2005</xref>]. Individuals with CNMs share common muscle biopsy features, most particularly the presence of central nuclei in affected skeletal muscle. Individuals with CNM unrelated to <italic toggle="yes">MTM1</italic> pathogenic variants tend to have less severe clinical symptomatology and do not typically exhibit the abnormal growth parameters seen in males with XLCNM. However, individuals with an &#x0201c;XLCNM-like&#x0201d; presentation and pathogenic variants in <italic toggle="yes">BIN1</italic>, <italic toggle="yes">DNM2</italic>, or <italic toggle="yes">RYR1</italic> have been reported (see following). Thus these genetic causes must be considered in children with the clinical and pathologic picture of XLCNM who do not have pathogenic variants in <italic toggle="yes">MTM1</italic>. Of note, the genetic basis for a fraction of individuals with CNM is as yet unknown. Newly identified CNM-related pathogenic variants will add to the differential diagnosis of XLCNM in the future.</p>
        <list list-type="bullet">
          <list-item>
            <p><bold><italic toggle="yes">DNM2</italic>-related CNM</bold> [<xref ref-type="bibr" rid="mtm.REF.bitoun.2005.1207">Bitoun et al 2005</xref>, <xref ref-type="bibr" rid="mtm.REF.bitoun.2007.666">Bitoun et al 2007</xref>, <xref ref-type="bibr" rid="mtm.REF.susman.2010.229">Susman et al 2010</xref>]. Pathogenic variants in <italic toggle="yes">DNM2</italic> are the second most common cause of CNM (after <italic toggle="yes">MTM1</italic>). <italic toggle="yes">DNM2</italic> pathogenic variants are either <italic toggle="yes">de novo</italic> (usually in severe cases) or inherited in an autosomal dominant manner. Several children with neonatal onset of hypotonia and weakness (particularly with pathogenic variants in the PH domain of <italic toggle="yes">DNM2</italic>) have been reported [<xref ref-type="bibr" rid="mtm.REF.bitoun.2007.666">Bitoun et al 2007</xref>, <xref ref-type="bibr" rid="mtm.REF.susman.2010.229">Susman et al 2010</xref>]. <italic toggle="yes">DNM2</italic>-related CNM may be distinguished by the presence of &#x0201c;spoke on wheel&#x0201d; changes with oxidative stains on muscle biopsy [<xref ref-type="bibr" rid="mtm.REF.romero.2010.223">Romero 2010</xref>]. Of note, progression of weakness has been observed during the teen years and in adulthood in several individuals with <italic toggle="yes">DNM2</italic> pathogenic variants [<xref ref-type="bibr" rid="mtm.REF.melberg.2010.53">Melberg et al 2010</xref>, <xref ref-type="bibr" rid="mtm.REF.susman.2010.229">Susman et al 2010</xref>].</p>
          </list-item>
          <list-item>
            <p><bold><italic toggle="yes">RYR1</italic>-related CNM</bold> [<xref ref-type="bibr" rid="mtm.REF.wilmshurst.2010.717">Wilmshurst et al 2010</xref>]. Pathogenic variants in the skeletal muscle ryanodine receptor have been reported in individuals with CNM, including in one boy originally diagnosed with XLCNM. Pathogenic variants in <italic toggle="yes">RYR1</italic> associated with CNM are most often inherited in an autosomal recessive manner and associated with diminished expression of the RyR1 protein. Affected individuals with heterozygous <italic toggle="yes">RYR1</italic> pathogenic variants have also been identified. Of note, the vast majority of <italic toggle="yes">RYR1</italic> pathogenic variants are associated with myopathies with cores (<related-object link-type="booklink" source-id="gene" document-id="cco" document-type="chapter">central core disease</related-object> and <related-object link-type="booklink" source-id="gene" document-id="mmd" document-type="chapter">minicore myopathy</related-object>).</p>
          </list-item>
          <list-item>
            <p><bold><italic toggle="yes">BIN1</italic>-related CNM</bold> [<xref ref-type="bibr" rid="mtm.REF.nicot.2007.1134">Nicot et al 2007</xref>]. Autosomal recessive pathogenic variants in <italic toggle="yes">BIN1</italic> have been described in a small group of individuals. The range of clinical severity is broad, though presentation in infancy has been reported [<xref ref-type="bibr" rid="mtm.REF.mejaddam.2009.91">Mejaddam et al 2009</xref>].</p>
          </list-item>
        </list>
        <p><bold>Other congenital myopathies</bold> (for a review, see <xref ref-type="bibr" rid="mtm.REF.sewry.2008.569">Sewry et al [2008]</xref>). Myotubular myopathy falls into the broad clinical classification of congenital myopathies. In general, each subtype of congenital myopathy is distinguished by characteristic features on muscle biopsy. However, initial biopsies in individuals with congenital myopathies, especially if taken in the first year of life, may not show the signature changes and may instead have nonspecific changes. Therefore, particularly in infancy, other congenital myopathies, including especially <related-object link-type="booklink" source-id="gene" document-id="nem" document-type="chapter">nemaline myopathy</related-object> and the subset of individuals with <related-object link-type="booklink" source-id="gene" document-id="mmd" document-type="chapter">minicore myopathy</related-object> who have ophthalmoparesis, must be considered on the differential diagnosis. Clinical features that are helpful for distinguishing XLCNM from other congenital myopathies include ophthalmoparesis, length greater than 90<sup>th</sup> percentile, and elongated features (facial and hands/feet).</p>
        <p><related-object link-type="booklink" source-id="gene" document-id="cms" document-type="chapter"><bold>Congenital myasthenic syndromes</bold></related-object>
<bold>(CMS)</bold> (for review, see <xref ref-type="bibr" rid="mtm.REF.engel.2008.285">Engel [2008]</xref> and <xref ref-type="bibr" rid="mtm.REF.palace.2008.2">Palace &#x00026; Beeson [2008]</xref>). Though rare, it is important to consider congenital myasthenic syndromes in boys being evaluated for myotubular myopathy; many infants with CMS will respond to medications that improve neuromuscular junction function.</p>
      </sec>
      <sec id="mtm.Management">
        <title>Management</title>
        <sec id="mtm.Evaluations_Following_Initial_Diagno">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease in an individual diagnosed with X-linked centronuclear myopathy (XLCNM), the following evaluations are recommended:</p>
          <list list-type="bullet">
            <list-item>
              <p>Assessment of pulmonary function for long-term ventilatory management, either during initial hospitalization (if presentation at birth) or after the diagnosis has been established.</p>
            </list-item>
            <list-item>
              <p>Ophthalmologic evaluation, either during initial hospitalization (if presentation at birth), or after the diagnosis has been established</p>
            </list-item>
            <list-item>
              <p>In individuals with hemolysis or unexplained anemia, osmotic fragility test to detect spherocytosis</p>
            </list-item>
            <list-item>
              <p>In the presence of infantile vomiting, investigation for pyloric stenosis</p>
            </list-item>
            <list-item>
              <p>Baseline abdominal ultrasound examination to detect peliosis hepatis (although the specific risk for subsequent bleeding if peliosis is detected is not known)</p>
            </list-item>
          </list>
        </sec>
        <sec id="mtm.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p>Management of individuals with XLCNM is based on supportive care measures and in large part is similar to that for other neuromuscular disorders. The management of an individual with XLCNM optimally involves a team of specialists with expertise in the long-term care of individuals with neuromuscular disorders. Such teams often include a pulmonologist, neurologist, physical therapist and/or rehabilitation medicine specialist, and clinical geneticist. Of note, standard of care measures for all congenital myopathies are currently being developed.</p>
          <p>Once the specific diagnosis of XLCNM is confirmed, management may be guided by family decisions regarding continued ventilatory support for the affected family member. Families may benefit from the involvement of professionals familiar with the data concerning the overall prognosis for XLCNM. Talking with other families who have children with the disorder can be extremely helpful (see <xref ref-type="sec" rid="mtm.Resources">Resources</xref>).</p>
          <list list-type="bullet">
            <list-item>
              <p>Because of the risks for aspiration pneumonia and respiratory failure in infants with moderate or severe disease, tracheostomy and G-tube feeding should be seriously considered. Even individuals with mild disease are at risk for significant morbidity and mortality from intercurrent respiratory infection and hypoventilation.</p>
            </list-item>
            <list-item>
              <p>For ventilator-dependent individuals, communication incorporates speech with a capped tracheostomy or Passy-Muir valve, sign language, and/or communication devices such as writing boards.</p>
            </list-item>
            <list-item>
              <p>Affected individuals older than age five years attend school, usually assisted by a dedicated nurse or aide, or have home-based teachers to limit exposure to infectious agents.</p>
            </list-item>
            <list-item>
              <p>Ophthalmologists, orthopedists specializing in scoliosis management, and orthodontists should address specific medical complications related to the underlying myopathy.</p>
            </list-item>
            <list-item>
              <p>Children with XLCNM and an unexpected decline in motor skills should be evaluated for a potential abnormality in neuromuscular junction function. A recent study from <xref ref-type="bibr" rid="mtm.REF.robb.2011.379">Robb et al [2011]</xref> identified one individual with mild XLCNM and unexplained decline in motor skills (i.e., lost ambulation) consistent with a disorder of neuromuscular junction transmission. On evaluation this individual was found to have the electrodiagnostic features of neuromuscular junction disease (electrodecrement with repetitive stimulation and jitter with single fiber EMG) but no laboratory evidence to support a co-occurring diagnosis of myasthenia gravis. Subsequent treatment with pyridostigmine resulted in rapid recovery of ambulation.</p>
            </list-item>
          </list>
        </sec>
        <sec id="mtm.Prevention_of_Secondary_Complication">
          <title>Prevention of Secondary Complications</title>
          <p>Because of the risks for bleeding during or following surgery, clotting parameters should be examined prior to any surgical procedures. (Note, however, that clotting studies in two individuals were normal prior to a lethal bleeding event associated with surgery.)</p>
        </sec>
        <sec id="mtm.Surveillance">
          <title>Surveillance</title>
          <p>Appropriate surveillance includes:</p>
          <list list-type="bullet">
            <list-item>
              <p>Annual pulmonary assessment, including pulmonary function testing if able to be performed;</p>
            </list-item>
            <list-item>
              <p>Polysomnography every one to three years unless symptoms of sleep-disordered breathing are present on history;</p>
            </list-item>
            <list-item>
              <p>Spinal examination for signs of scoliosis, particularly in late childhood and adolescence;</p>
            </list-item>
            <list-item>
              <p>Annual ophthalmologic exams for ophthalmoplegia, ptosis, and myopia;</p>
            </list-item>
            <list-item>
              <p>Assessment for dental malocclusion, with referral for orthodontia if indicated.</p>
            </list-item>
          </list>
          <p>Currently, the risk for non-neurologic events including bleeding diatheses and gastrointestinal complications is uncertain. Furthermore, the benefit of screening tests for such abnormalities has yet to be determined or systematically studied. Potential screening tests include the following:</p>
          <list list-type="bullet">
            <list-item>
              <p>Annual blood counts [<xref ref-type="bibr" rid="mtm.REF.herman.1999.206">Herman et al 1999</xref>]</p>
            </list-item>
            <list-item>
              <p>Annual liver function test and abdominal ultrasound to address the potential risk of peliosis hepatis [<xref ref-type="bibr" rid="mtm.REF.herman.1999.206">Herman et al 1999</xref>]</p>
            </list-item>
          </list>
        </sec>
        <sec id="mtm.Evaluation_of_Relatives_at_Risk">
          <title>Evaluation of Relatives at Risk</title>
          <p>See <xref ref-type="sec" rid="mtm.Related_Genetic_Counseling_Issues">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="mtm.Therapies_Under_Investigation">
          <title>Therapies Under Investigation</title>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov/">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p>
        </sec>
      </sec>
      <sec id="mtm.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="mtm.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p>X-linked centronuclear myopathy (XLCNM) is inherited in an X-linked manner.</p>
        </sec>
        <sec id="mtm.Risk_to_Family_Members">
          <title>Risk to Family Members</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The father of an affected male will not have the disease nor will he be a carrier of the pathogenic variant.</p>
            </list-item>
            <list-item>
              <p>A woman with an affected son and one other affected male relative in the maternal lineage is an obligate carrier.</p>
            </list-item>
            <list-item>
              <p>If a woman has more than one affected son and the pathogenic variant identified in a son cannot be detected in DNA extracted from her leukocytes, she has germline mosaicism.</p>
            </list-item>
            <list-item>
              <p>The carrier risk for a woman whose son has a confirmed <italic toggle="yes">MTM1</italic> pathogenic variant and is the sole affected male in the family is 80%-90% [<xref ref-type="bibr" rid="mtm.REF.laporte.2000.393">Laporte et al 2000</xref>, <xref ref-type="bibr" rid="mtm.REF.herman.2002.114">Herman et al 2002</xref>]. Thus, about 10%-20% of affected males who are the only affected individual in the family have <italic toggle="yes">de novo</italic> pathogenic variants in <italic toggle="yes">MTM1</italic> and mothers who are not carriers.</p>
            </list-item>
          </list>
          <p>
            <bold>Sibs of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The risk to sibs of a male proband depends on the carrier status of the mother.</p>
            </list-item>
            <list-item>
              <p>If the mother is a carrier, there is a 50% chance of transmitting the <italic toggle="yes">MTM1</italic> pathogenic variant in each pregnancy. Male sibs who inherit the pathogenic variant will be affected; female sibs who inherit the variant will be carriers and will generally not be affected.</p>
            </list-item>
            <list-item>
              <p>Because of the possibility of germline mosaicism, sibs of a proband are at risk even if the <italic toggle="yes">MTM1</italic> pathogenic variant found in the proband is not detected in DNA extracted from the mother's leukocytes.</p>
            </list-item>
          </list>
          <p><bold>Offspring of a proband.</bold> In general, affected males do not reproduce. However, <xref ref-type="bibr" rid="mtm.REF.biancalana.2003.135">Biancalana et al [2003]</xref> reported an affected male with mild disease detected at age 20 who fathered two unaffected daughters, both of whom had affected sons. Affected males who do reproduce will pass the pathogenic variant to all of their daughters and none of their sons.</p>
          <p><bold>Other family members.</bold> The proband's maternal aunts may be at risk of being carriers and the aunt's offspring, depending on their gender, may be at risk of being carriers or of being affected.</p>
        </sec>
        <sec id="mtm.Carrier_Detection">
          <title>Carrier Detection</title>
          <p>Carrier testing of at-risk female relatives is possible if the pathogenic variant has been identified in the proband.</p>
        </sec>
        <sec id="mtm.Related_Genetic_Counseling_Issues">
          <title>Related Genetic Counseling Issues</title>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk, clarification of carrier status, and discussion of the availability of prenatal testing is before pregnancy.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are carriers or are at risk of being carriers.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.</p>
        </sec>
        <sec id="mtm.Prenatal_Testing">
          <title>Prenatal Testing</title>
          <p>Prenatal testing is possible for pregnancies of women who are carriers. The usual procedure is to determine fetal sex by performing chromosome analysis on fetal cells obtained by chorionic villus sampling (CVS) at about ten to 12 weeks' gestation or by amniocentesis usually performed at about 15 to 18 weeks' gestation. If the karyotype is 46,XY and if the pathogenic variant has been identified in a family member, DNA from fetal cells can be analyzed for the known pathogenic variant. Penetrance appears to be 100% in affected males; disease severity is usually similar in affected sibs.</p>
          <p>Note: Gestational age is expressed as menstrual weeks calculated either from the first day of the last normal menstrual period or by ultrasound measurements.</p>
          <p>Several instances of germline mosaicism for <italic toggle="yes">MTM1</italic> pathogenic variants have been described [<xref ref-type="bibr" rid="mtm.REF.vincent.1998.241">Vincent et al 1998</xref>, <xref ref-type="bibr" rid="mtm.REF.h_ne.1999.77">H&#x000e4;ne et al 1999</xref>, <xref ref-type="bibr" rid="mtm.REF.laporte.2000.393">Laporte et al 2000</xref>]. Thus, it is important to discuss the option of prenatal testing in a male fetus even in instances in which the pathogenic variant is not identified in DNA extracted from the mother's leukocytes.</p>
          <p><bold>Preimplantation genetic diagnosis (PGD)</bold> may be an option for some families in which the pathogenic variant has been identified.</p>
        </sec>
      </sec>
      <sec id="mtm.Resources">
        <title>Resources</title>
      </sec>
      <sec id="mtm.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <p><bold>Gene structure.</bold>
<italic toggle="yes">MTM1</italic> is approximately 90 kb in size and comprises 15 exons. The first exon is non-coding and encompasses the putative promoter region of the gene. The start codon is present in exon 2. The gene is ubiquitously expressed and shows a muscle-specific alternative transcript because of the use of a different polyadenylation signal [<xref ref-type="bibr" rid="mtm.REF.laporte.1996.175">Laporte et al 1996</xref>]. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="mtm" object-id="mtm.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
        <p><bold>Benign allelic variants.</bold> To date, approximately 20-23 different benign variants have been identified in <italic toggle="yes">MTM1</italic> [<xref ref-type="bibr" rid="mtm.REF.laporte.2000.393">Laporte et al 2000</xref>; <xref ref-type="bibr" rid="mtm.REF.herman.2002.114">Herman et al 2002</xref>; Das, personal communication]. The polymorphic changes that have been identified are thought not to be disease causing, as they have been found either in individuals in whom a clearly pathogenic variant is also present or in individuals without the disease. The majority of changes identified represent rare variants, with the exception of c.1260+3G&#x0003e;A, which occurs at a frequency of approximately 50% [<xref ref-type="bibr" rid="mtm.REF.laporte.2000.393">Laporte et al 2000</xref>].</p>
        <p><bold>Pathogenic allelic variants.</bold> Approximately 230 different variants that cause X-linked centronuclear myopathy have been described [<xref ref-type="bibr" rid="mtm.REF.laporte.2000.393">Laporte et al 2000</xref>, <xref ref-type="bibr" rid="mtm.REF.herman.2002.114">Herman et al 2002</xref>, <xref ref-type="bibr" rid="mtm.REF.biancalana.2003.135">Biancalana et al 2003</xref>, <xref ref-type="bibr" rid="mtm.REF.bertini.2004.387">Bertini et al 2004</xref>, <xref ref-type="bibr" rid="mtm.REF.tsai.2005.245">Tsai et al 2005</xref>, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.hgmd.org">Human Gene Mutation Database</ext-link> (HGMD)]. Pathogenic variants are evenly distributed throughout the gene with no hot spots. While some pathogenic variants appear to be recurrent, no predominant common variant has been identified in any population.</p>
        <table-wrap id="mtm.T.selected_mtm1_allelic_variants" position="anchor" orientation="portrait">
          <label>Table 2. </label>
          <caption>
            <p>Selected <italic toggle="yes">MTM1</italic> Allelic Variants</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th id="hd_h_mtm.T.selected_mtm1_allelic_variants_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Variant Classification</th>
                <th id="hd_h_mtm.T.selected_mtm1_allelic_variants_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change</th>
                <th id="hd_h_mtm.T.selected_mtm1_allelic_variants_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Predicted Protein Change</th>
                <th id="hd_h_mtm.T.selected_mtm1_allelic_variants_1_1_1_4" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequences</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td headers="hd_h_mtm.T.selected_mtm1_allelic_variants_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <bold>Benign</bold>
                </td>
                <td headers="hd_h_mtm.T.selected_mtm1_allelic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">c.1260+3G&#x0003e;A</td>
                <td headers="hd_h_mtm.T.selected_mtm1_allelic_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">NA</td>
                <td headers="hd_h_mtm.T.selected_mtm1_allelic_variants_1_1_1_4" rowspan="11" valign="middle" align="left" colspan="1">
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_000252.2">NM_000252.2</ext-link>
                  <break/>
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/NP_000243.1">NP_000243.1</ext-link>
                </td>
              </tr>
              <tr>
                <td headers="hd_h_mtm.T.selected_mtm1_allelic_variants_1_1_1_1" rowspan="10" valign="middle" align="left" scope="row" colspan="1">
                  <bold>Pathogenic</bold>
                </td>
                <td headers="hd_h_mtm.T.selected_mtm1_allelic_variants_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">c.109C&#x0003e;T</td>
                <td headers="hd_h_mtm.T.selected_mtm1_allelic_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Arg37Ter</td>
              </tr>
              <tr>
                <td headers="hd_h_mtm.T.selected_mtm1_allelic_variants_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.142G&#x0003e;T</td>
                <td headers="hd_h_mtm.T.selected_mtm1_allelic_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Glu48Ter</td>
              </tr>
              <tr>
                <td headers="hd_h_mtm.T.selected_mtm1_allelic_variants_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.205C&#x0003e;T</td>
                <td headers="hd_h_mtm.T.selected_mtm1_allelic_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Arg69Cys</td>
              </tr>
              <tr>
                <td headers="hd_h_mtm.T.selected_mtm1_allelic_variants_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.141_144delAGAA</td>
                <td headers="hd_h_mtm.T.selected_mtm1_allelic_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Glu48LeufsTer24</td>
              </tr>
              <tr>
                <td headers="hd_h_mtm.T.selected_mtm1_allelic_variants_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.614C&#x0003e;T</td>
                <td headers="hd_h_mtm.T.selected_mtm1_allelic_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Pro205Leu</td>
              </tr>
              <tr>
                <td headers="hd_h_mtm.T.selected_mtm1_allelic_variants_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.674T&#x0003e;C</td>
                <td headers="hd_h_mtm.T.selected_mtm1_allelic_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Ile225Thr</td>
              </tr>
              <tr>
                <td headers="hd_h_mtm.T.selected_mtm1_allelic_variants_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.721C&#x0003e;T</td>
                <td headers="hd_h_mtm.T.selected_mtm1_allelic_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Arg241Cys</td>
              </tr>
              <tr>
                <td headers="hd_h_mtm.T.selected_mtm1_allelic_variants_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.1261C&#x0003e;T</td>
                <td headers="hd_h_mtm.T.selected_mtm1_allelic_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Arg421Ter</td>
              </tr>
              <tr>
                <td headers="hd_h_mtm.T.selected_mtm1_allelic_variants_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.1262G&#x0003e;A</td>
                <td headers="hd_h_mtm.T.selected_mtm1_allelic_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Arg421Gln</td>
              </tr>
              <tr>
                <td headers="hd_h_mtm.T.selected_mtm1_allelic_variants_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.1261-10A&#x0003e;G</td>
                <td headers="hd_h_mtm.T.selected_mtm1_allelic_variants_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">NA</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn>
              <p>Note on variant classification: Variants listed in the table have been provided by the authors. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
            </fn>
            <fn>
              <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
            </fn>
            <fn>
              <p>NA = not applicable</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <p><bold>Normal gene product.</bold>
<italic toggle="yes">MTM1</italic> encodes myotubularin, a protein of 603 amino acids [<xref ref-type="bibr" rid="mtm.REF.laporte.1996.175">Laporte et al 1996</xref>, <xref ref-type="bibr" rid="mtm.REF.laporte.1998b.325">Laporte et al 1998b</xref>].</p>
        <p>Myotubularin was originally characterized as a protein tyrosine phosphatase [<xref ref-type="bibr" rid="mtm.REF.laporte.1998a.1703">Laporte et al 1998a</xref>], but was subsequently found instead to function primarily as a lipid phosphatase [<xref ref-type="bibr" rid="mtm.REF.taylor.2000.8910">Taylor et al 2000</xref>], specifically acting to remove phosphates from the 3-position of phosphoinositides. Studies using both cell-free biochemical assays and forced exogenous expression in cell culture have shown that myotubularin converts phosphoinositide-3-phosphate (PI3P) to phosphoinositide phosphate (PIP) and phosphoinositide-3,5-bisphosphate (PI3,5P2) to phosphoinositide-5-phosphate (PI5P) [<xref ref-type="bibr" rid="mtm.REF.taylor.2000.8910">Taylor et al 2000</xref>, <xref ref-type="bibr" rid="mtm.REF.chaussade.2003.2448">Chaussade et al 2003</xref>, <xref ref-type="bibr" rid="mtm.REF.robinson.2006.403">Robinson &#x00026; Dixon 2006</xref>]. Myotubularin&#x02019;s cellular function is inferred in part from the known roles of the phosphoinositides (PIs) upon which it acts [<xref ref-type="bibr" rid="mtm.REF.dowling.2008.1035">Dowling et al 2008</xref>]. Based on the localization and function of PI3P and PI3,5P2, myotubularin is presumed to be a critical regulator of endosomal dynamics [<xref ref-type="bibr" rid="mtm.REF.clague.2005.1063">Clague &#x00026; Lorenzo 2005</xref>]. Support for this role comes from a series of in vitro studies. Using both anti-myotubularin antibodies and expression-tagged myotubularin constructs, studies have found that the protein localizes to endosomes in a variety of cell types [<xref ref-type="bibr" rid="mtm.REF.laporte.2002.3105">Laporte et al 2002</xref>, <xref ref-type="bibr" rid="mtm.REF.tsujita.2004.13817">Tsujita et al 2004</xref>, <xref ref-type="bibr" rid="mtm.REF.cao.2007.1052">Cao et al 2007</xref>]. Overexpression or siRNA knockdown of myotubularin results in altered PI3P levels and interruption of the normal traffic between endosomes and lysosomes. It also causes abnormalities in the recycling of internalized receptors. The prevailing hypothesis concerning myotubularin function is that the protein helps control the flow of membranes through the endosomal compartment by rapidly removing PI3P and PI3,5P2 and altering the profile of bound effector molecules on the relevant membrane subdomains [<xref ref-type="bibr" rid="mtm.REF.dowling.2008.1035">Dowling et al 2008</xref>]. How this function relates to the role of MTM1 in skeletal muscle is currently unknown.</p>
        <p>Myotubularin likely has roles in other cellular processes as well. Much of the protein does not localize to endosomes, but is instead at steady state in a dense cytoplasmic network and can be found transiently at Rac-induced membrane ruffles [<xref ref-type="bibr" rid="mtm.REF.laporte.2002.3105">Laporte et al 2002</xref>]. It has been recently shown to interact with the intermediate filament network and specifically with desmin [<xref ref-type="bibr" rid="mtm.REF.hnia.2011.70">Hnia et al 2011</xref>]. This interaction may both mediate myotubularin localization and also enable myotubularin to participate as a regulator of mitochondrial dynamics.</p>
        <p>Myotubularin was the first described member of a large group of homologous, evolutionarily conserved proteins. To date, 14 myotubularin-related (or MTMR) proteins have been characterized [<xref ref-type="bibr" rid="mtm.REF.robinson.2006.403">Robinson &#x00026; Dixon 2006</xref>]. Eight of the 14 have dual specificity phosphatase activity identical to myotubularin. The remaining six have non-functional phosphatase domains, and are thought to act as co-activators or regulators of the enzymatically active members of the family. For example, myotubularin interacts directly with the non-catalytic MTMR12 [<xref ref-type="bibr" rid="mtm.REF.lorenzo.2006.2953">Lorenzo et al 2006</xref>]. Like myotubularin, several MTMRs are critical for mammalian development and human neurologic disease. <italic toggle="yes">MTMR2</italic> and <italic toggle="yes">SBF2</italic> (formerly <italic toggle="yes">MTMR13</italic>) pathogenic variants cause Charcot-Marie-Tooth disease type 4B1 and type 4B2 [<xref ref-type="bibr" rid="mtm.REF.bolino.2000.17">Bolino et al 2000</xref>, <xref ref-type="bibr" rid="mtm.REF.azzedine.2003.1141">Azzedine et al 2003</xref>, <xref ref-type="bibr" rid="mtm.REF.senderek.2003.349">Senderek et al 2003</xref>, <xref ref-type="bibr" rid="mtm.REF.bolis.2007.308">Bolis et al 2007</xref>], a demyelinating peripheral neuropathy, and sequence variants in <italic toggle="yes">MTMR14</italic> are associated with autosomal recessive centronuclear myopathy [<xref ref-type="bibr" rid="mtm.REF.tosch.2006.3098">Tosch et al 2006</xref>].</p>
        <p><bold>Abnormal gene product.</bold> Pathogenic variants in <italic toggle="yes">MTM1</italic> result in loss of function or absence of the myotubularin protein. Disease is mediated at least in part by loss of myotubularin&#x02019;s phosphatase activity, as missense variants that impair myotubularin&#x02019;s enzymatic activity are associated with the severe/classic phenotype. Pathogenic variants that do not affect the enzymatic domain support the hypothesis that myotubularin has functions in addition to phosphatase activity. The mechanism(s) whereby lack or dysfunction of myotubularin produces the disease phenotype seen in XLCNM have recently come into focus. This knowledge has been particularly advanced by the recent development of model organisms (specifically in <italic toggle="yes">Drosophila</italic> [<xref ref-type="bibr" rid="mtm.REF.ribeiro.2011.e1001295">Ribeiro et al 2011</xref>], zebrafish [<xref ref-type="bibr" rid="mtm.REF.dowling.2009.e1000372">Dowling et al 2009</xref>], mouse [<xref ref-type="bibr" rid="mtm.REF.bujbello.2002.15060">Buj-Bello et al 2002</xref>, <xref ref-type="bibr" rid="mtm.REF.alqusairi.2009.18763">Al-Qusairi et al 2009</xref>], and dog [<xref ref-type="bibr" rid="mtm.REF.beggs.2010.14697">Beggs et al 2010</xref>]) that accurately reflect the genetic and pathophysiologic aspects of the disease. Based on data from these models, the weakness in myotubular myopathy is caused, at least in part, by defective excitation-contraction (E-C) coupling. E-C coupling is the process by which electrical stimuli at the neuromuscular junction are translated into muscle contraction. It is mediated by the triad, a structure composed of the T-tubule and the terminal sarcoplasmic reticulum; the triad is responsible for regulated calcium release. Loss of myotubularin results in abnormalities in the structure of the triad as well as impaired stimulus-dependent calcium release. These abnormalities are observed early in the disease process in all model systems examined, and are thus likely an early pathogenic event in humans with XLCNM. Interestingly, abnormalities in the E-C coupling apparatus have been observed in the genetically determined autosomal forms of centronuclear myopathy, thus suggesting a common pathogenic mechanism for all types of CNM [<xref ref-type="bibr" rid="mtm.REF.toussaint.2011.253">Toussaint et al 2011</xref>].</p>
        <p>Loss of myotubularin likely affects other aspects of muscle function as well. In the zebrafish model of XLCNM, disorganization of the neuromuscular junction has been reported [<xref ref-type="bibr" rid="mtm.REF.robb.2011.379">Robb et al 2011</xref>]. In the mouse model and in cells derived from biopsies of affected persons, abnormal mitochondrial function has been described [<xref ref-type="bibr" rid="mtm.REF.hnia.2011.70">Hnia et al 2011</xref>]. The specific contribution(s) to the disease phenotype of these changes remain to be determined.</p>
      </sec>
      <sec id="mtm.References">
        <title>References</title>
        <sec id="mtm.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="mtm.Literature_Cited.reflist0">
            <ref id="mtm.REF.alqusairi.2009.18763">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Al-Qusairi</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weiss</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Toussaint</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berby</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Messaddeq</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kretz</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sanoudou</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beggs</surname>
                    <given-names>AH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Allard</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mandel</surname>
                    <given-names>J-L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jacquemond</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Buj-Bello</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>T-tubule disorganization and defective excitation-contraction coupling in muscle fibers lacking myotubularin lipid phosphatase.</article-title>
                <source>Proc Natl Acad Sci (USA)</source>
                <volume>106</volume>
                <fpage>18763</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">19846786</pub-id>
              </element-citation>
            </ref>
            <ref id="mtm.REF.azzedine.2003.1141">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Azzedine</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bolino</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taieb</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Birouk</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Di Duca</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bouhouche</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Benamou</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mrabet</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hammadouche</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chkili</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gouider</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ravazzolo</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brice</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Laporte</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>LeGuern</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Mutations in MTMR13, a new pseudophosphatase homologue of MTMR2 and Sbf1, in two families with an autosomal recessive demyelinating form of Charcot-Marie-Tooth disease associated with early-onset glaucoma.</article-title>
                <source>Am J Hum Genet</source>
                <volume>72</volume>
                <fpage>1141</fpage>
                <lpage>53</lpage>
                <pub-id pub-id-type="pmid">12687498</pub-id>
              </element-citation>
            </ref>
            <ref id="mtm.REF.barth.1998.49">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Barth</surname>
                    <given-names>PG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dubowitz</surname>
                    <given-names>V</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>X-linked myotubular myopathy--a long-term follow-up study.</article-title>
                <source>Eur J Paediatr Neurol</source>
                <volume>2</volume>
                <fpage>49</fpage>
                <lpage>56</lpage>
                <pub-id pub-id-type="pmid">10726846</pub-id>
              </element-citation>
            </ref>
            <ref id="mtm.REF.bartsch.1999.310">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bartsch</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kress</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wagner</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seemanova</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>The novel contiguous gene syndrome of myotubular myopathy (MTM1), male hypogenitalism and deletion in Xq28:report of the first familial case.</article-title>
                <source>Cytogenet Cell Genet</source>
                <volume>85</volume>
                <fpage>310</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">10449925</pub-id>
              </element-citation>
            </ref>
            <ref id="mtm.REF.beggs.2010.14697">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Beggs</surname>
                    <given-names>AH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>B&#x000f6;hm</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Snead</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kozlowski</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maurer</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Minor</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Childers</surname>
                    <given-names>MK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taylor</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hitte</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mickelson</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guo</surname>
                    <given-names>LT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mizisin</surname>
                    <given-names>AP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Buj-Bello</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tiret</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Laporte</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shelton</surname>
                    <given-names>GD</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>MTM1 mutation associated with X-linked myotubular myopathy in Labrador Retrievers.</article-title>
                <source>Proc Natl Acad Sci U S A.</source>
                <volume>107</volume>
                <fpage>14697</fpage>
                <lpage>702</lpage>
                <pub-id pub-id-type="pmid">20682747</pub-id>
              </element-citation>
            </ref>
            <ref id="mtm.REF.bertini.2004.387">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bertini</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Biancalana</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bolino</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Buj Bello</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Clague</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guicheney</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jungbluth</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kress</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Musaro'</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nandurkar</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pirola</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Romero</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Senderek</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suter</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sewry</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tronchere</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wallgren-Pettersson</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wishart</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Laporte</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>118th ENMC International Workshop on Advances in Myotubular Myopathy. 26-28 September 2003, Naarden, The Netherlands. (5th Workshop of the International Consortium on Myotubular Myopathy).</article-title>
                <source>Neuromuscul Disord.</source>
                <volume>14</volume>
                <fpage>387</fpage>
                <lpage>96</lpage>
                <pub-id pub-id-type="pmid">15145343</pub-id>
              </element-citation>
            </ref>
            <ref id="mtm.REF.bevilacqua.2009.283">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bevilacqua</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bitoun</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Biancalana</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oldfors</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stoltenburg</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Claeys</surname>
                    <given-names>KG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lac&#x000e8;ne</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brochier</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Man&#x000e9;r&#x000e9;</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lafor&#x000ea;t</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eymard</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guicheney</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fardeau</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Romero</surname>
                    <given-names>NB</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>"Necklace" fibers, a new histological marker of late-onset MTM1-related centronuclear myopathy.</article-title>
                <source>Acta Neuropathol.</source>
                <volume>117</volume>
                <fpage>283</fpage>
                <lpage>91</lpage>
                <pub-id pub-id-type="pmid">19084976</pub-id>
              </element-citation>
            </ref>
            <ref id="mtm.REF.biancalana.2003.135">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Biancalana</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Caron</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gallati</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baas</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kress</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Novelli</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>D'Apice</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lagier-Tourenne</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Buj-Bello</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Romero</surname>
                    <given-names>NB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mandel</surname>
                    <given-names>JL</given-names>
                  </name>
                </person-group>
                <article-title>Characterisation of mutations in 77 patients with X-linked myotubular myopathy, including a family with a very mild phenotype.</article-title>
                <source>Hum Genet.</source>
                <year>2003</year>
                <volume>112</volume>
                <fpage>135</fpage>
                <lpage>42</lpage>
                <pub-id pub-id-type="pmid">12522554</pub-id>
              </element-citation>
            </ref>
            <ref id="mtm.REF.bitoun.2007.666">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bitoun</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bevilacqua</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Prudhon</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maugenre</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taratuto</surname>
                    <given-names>AL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Monges</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lubieniecki</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cances</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uro-Coste</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mayer</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fardeau</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Romero</surname>
                    <given-names>NB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guicheney</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Dynamin 2 mutations cause sporadic centronuclear myopathy with neonatal onset.</article-title>
                <source>Ann Neurol.</source>
                <volume>62</volume>
                <fpage>666</fpage>
                <lpage>70</lpage>
                <pub-id pub-id-type="pmid">17932957</pub-id>
              </element-citation>
            </ref>
            <ref id="mtm.REF.bitoun.2005.1207">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bitoun</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maugenre</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jeannet</surname>
                    <given-names>PY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lacene</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferrer</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Laforet</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martin</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Laporte</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lochmuller</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beggs</surname>
                    <given-names>AH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fardeau</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eymard</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Romero</surname>
                    <given-names>NB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guicheney</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Mutations in dynamin 2 cause dominant centronuclear myopathy.</article-title>
                <source>Nat Genet</source>
                <volume>37</volume>
                <fpage>1207</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">16227997</pub-id>
              </element-citation>
            </ref>
            <ref id="mtm.REF.bolino.2000.17">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bolino</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muglia</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Conforti</surname>
                    <given-names>FL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>LeGuern</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Salih</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Georgiou</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Christodoulou</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hausmanowa-Petrusewicz</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mandich</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schenone</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gambardella</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bono</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Quattrone</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Devoto</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Monaco</surname>
                    <given-names>AP</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Charcot-Marie-Tooth type 4B is caused by mutations in the gene encoding myotubularin-related protein-2.</article-title>
                <source>Nat Genet</source>
                <volume>25</volume>
                <fpage>17</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">10802647</pub-id>
              </element-citation>
            </ref>
            <ref id="mtm.REF.bolis.2007.308">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bolis</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zordan</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Coviello</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bolino</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Myotubularin-related (MTMR) phospholipid phosphatase proteins in the peripheral nervous system.</article-title>
                <source>Mol Neurobiol.</source>
                <volume>35</volume>
                <fpage>308</fpage>
                <lpage>16</lpage>
                <pub-id pub-id-type="pmid">17917119</pub-id>
              </element-citation>
            </ref>
            <ref id="mtm.REF.bujbello.1999.320">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Buj-Bello</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Biancalana</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moutou</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Laporte</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mandel</surname>
                    <given-names>JL</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Identification of novel mutations in the MTM1 gene causing severe and mild forms of X-linked myotubular myopathy.</article-title>
                <source>Hum Mutat</source>
                <volume>14</volume>
                <fpage>320</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">10502779</pub-id>
              </element-citation>
            </ref>
            <ref id="mtm.REF.bujbello.2002.15060">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Buj-Bello</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Laugel</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Messaddeq</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zahreddine</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Laporte</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pellissier</surname>
                    <given-names>JF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mandel</surname>
                    <given-names>JL</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>The lipid phosphatase myotubularin is essential for skeletal muscle maintenance but not for myogenesis in mice.</article-title>
                <source>Proc Natl Acad Sci U S A</source>
                <volume>99</volume>
                <fpage>15060</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">12391329</pub-id>
              </element-citation>
            </ref>
            <ref id="mtm.REF.cahill.2007.98">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Cahill</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rinella</surname>
                    <given-names>AS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bielski</surname>
                    <given-names>RJ</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Orthopaedic complications of myotubular myopathy.</article-title>
                <source>J Pediatr Orthop.</source>
                <volume>27</volume>
                <fpage>98</fpage>
                <lpage>103</lpage>
                <pub-id pub-id-type="pmid">17195806</pub-id>
              </element-citation>
            </ref>
            <ref id="mtm.REF.cao.2007.1052">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Cao</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Laporte</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Backer</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wandinger-Ness</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stein</surname>
                    <given-names>MP</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Myotubularin lipid phosphatase binds the hVPS15/hVPS34 lipid kinase complex on endosomes.</article-title>
                <source>Traffic.</source>
                <volume>8</volume>
                <fpage>1052</fpage>
                <lpage>67</lpage>
                <pub-id pub-id-type="pmid">17651088</pub-id>
              </element-citation>
            </ref>
            <ref id="mtm.REF.chaussade.2003.2448">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chaussade</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pirola</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonnafous</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blondeau</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brenz-Verca</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tronch&#x000e8;re</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Portis</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rusconi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Payrastre</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Laporte</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Obberghen</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Expression of myotubularin by an adenoviral vector demonstrates its function as a phosphatidylinositol 3-phosphate [PtdIns(3)P] phosphatase in muscle cell lines: involvement of PtdIns(3)P in insulin-stimulated glucose transport.</article-title>
                <source>Mol Endocrinol.</source>
                <volume>17</volume>
                <fpage>2448</fpage>
                <lpage>60</lpage>
                <pub-id pub-id-type="pmid">14500759</pub-id>
              </element-citation>
            </ref>
            <ref id="mtm.REF.clague.2005.1063">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Clague</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lorenzo</surname>
                    <given-names>O</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>The myotubularin family of lipid phosphatases.</article-title>
                <source>Traffic.</source>
                <volume>6</volume>
                <fpage>1063</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">16262718</pub-id>
              </element-citation>
            </ref>
            <ref id="mtm.REF.copley.2002.256">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Copley</surname>
                    <given-names>LM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhao</surname>
                    <given-names>WD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kopacz</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Herman</surname>
                    <given-names>GE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kioschis</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Poustka</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taudien</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Platzer</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Exclusion of mutations in the MTMR1 gene as a frequent cause of X- linked myotubular myopathy.</article-title>
                <source>Am J Med Genet</source>
                <volume>107</volume>
                <fpage>256</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">11807911</pub-id>
              </element-citation>
            </ref>
            <ref id="mtm.REF.cox.2005.441">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Cox</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gattas</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harvey</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dolphin</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Friend</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yu</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>X-linked myotubular myopathy: mutation R69C identified in a family with multiple neonatal deaths.</article-title>
                <source>Clin Genet</source>
                <volume>67</volume>
                <fpage>441</fpage>
                <lpage>2</lpage>
                <pub-id pub-id-type="pmid">15811014</pub-id>
              </element-citation>
            </ref>
            <ref id="mtm.REF.dahl.1995.1108">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Dahl</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hu</surname>
                    <given-names>LJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chery</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fardeau</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gilgenkrantz</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nivelon-Chevallier</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sidaner-Noisette</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mugneret</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gouyon</surname>
                    <given-names>JB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gal</surname>
                    <given-names>A</given-names>
                  </name>
                  <etal/>
                </person-group>
                <year>1995</year>
                <article-title>Myotubular myopathy in a girl with a deletion at Xq27-q28 and unbalanced X inactivation assigns the MTM1 gene to a 600-kb region.</article-title>
                <source>Am J Hum Genet</source>
                <volume>56</volume>
                <fpage>1108</fpage>
                <lpage>15</lpage>
                <pub-id pub-id-type="pmid">7726166</pub-id>
              </element-citation>
            </ref>
            <ref id="mtm.REF.de_goede.2005.835">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>de Goede</surname>
                    <given-names>CG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kelsey</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kingston</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tomlin</surname>
                    <given-names>PI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hughes</surname>
                    <given-names>MI</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Muscle biopsy without centrally located nuclei in a male child with mild X-linked myotubular myopathy.</article-title>
                <source>Dev Med Child Neurol</source>
                <volume>47</volume>
                <fpage>835</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">16288675</pub-id>
              </element-citation>
            </ref>
            <ref id="mtm.REF.de_gouyon.1997.1499">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>de Gouyon</surname>
                    <given-names>BM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhao</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Laporte</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mandel</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Metzenberg</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Herman</surname>
                    <given-names>GE</given-names>
                  </name>
                </person-group>
                <year>1997</year>
                <article-title>Characterization of mutations in the myotubularin gene in twenty six patients with X-linked myotubular myopathy.</article-title>
                <source>Hum Mol Genet</source>
                <volume>6</volume>
                <fpage>1499</fpage>
                <lpage>504</lpage>
                <pub-id pub-id-type="pmid">9285787</pub-id>
              </element-citation>
            </ref>
            <ref id="mtm.REF.dowling.2008.1035">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Dowling</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gibbs</surname>
                    <given-names>EM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Feldman</surname>
                    <given-names>EL</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Membrane traffic and muscle: lessons from human disease.</article-title>
                <source>Traffic.</source>
                <volume>9</volume>
                <fpage>1035</fpage>
                <lpage>43</lpage>
                <pub-id pub-id-type="pmid">18266915</pub-id>
              </element-citation>
            </ref>
            <ref id="mtm.REF.dowling.2009.e1000372">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Dowling</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vreede</surname>
                    <given-names>AP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Low</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gibbs</surname>
                    <given-names>EM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kuwada</surname>
                    <given-names>JY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonnemann</surname>
                    <given-names>CG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Feldman</surname>
                    <given-names>EL</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Loss of myotubularin function results in T-tubule disorganization in zebrafish and human myotubular myopathy.</article-title>
                <source>PLoS Genet.</source>
                <volume>5</volume>
                <fpage>e1000372</fpage>
                <pub-id pub-id-type="pmid">19197364</pub-id>
              </element-citation>
            </ref>
            <ref id="mtm.REF.dubowitz.2006">
              <mixed-citation publication-type="book">Dubowitz V, Sewry CA. <italic toggle="yes">Muscle Biopsy: A Practical Approach</italic>. 3 ed. London: Saunders Elsevier; 2006.</mixed-citation>
            </ref>
            <ref id="mtm.REF.engel.2008.285">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Engel</surname>
                    <given-names>AG</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Congenital myasthenic syndromes.</article-title>
                <source>Handb Clin Neurol.</source>
                <volume>91</volume>
                <fpage>285</fpage>
                <lpage>331</lpage>
                <pub-id pub-id-type="pmid">18631848</pub-id>
              </element-citation>
            </ref>
            <ref id="mtm.REF.flex.2002.501">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Flex</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Luca</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>D'Apice</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Buccino</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dallapiccola</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Novelli</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Rapid scanning of myotubularin (MTM1) gene by denaturing high-performance liquid chromatography (DHPLC).</article-title>
                <source>Neuromuscul Disord</source>
                <volume>12</volume>
                <fpage>501</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">12031625</pub-id>
              </element-citation>
            </ref>
            <ref id="mtm.REF.grogan.2005.1638">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Grogan</surname>
                    <given-names>PM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tanner</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>&#x000d8;rstavik</surname>
                    <given-names>KH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Knudsen</surname>
                    <given-names>GP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saperstein</surname>
                    <given-names>DS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vogel</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barohn</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Herbelin</surname>
                    <given-names>LL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McVey</surname>
                    <given-names>AL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Katz</surname>
                    <given-names>JS</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Myopathy with skeletal asymmetry and hemidiaphragm elevation is caused by myotubularin mutations.</article-title>
                <source>Neurology.</source>
                <volume>64</volume>
                <fpage>1638</fpage>
                <lpage>40</lpage>
                <pub-id pub-id-type="pmid">15883335</pub-id>
              </element-citation>
            </ref>
            <ref id="mtm.REF.hammans.2000.133">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hammans</surname>
                    <given-names>SR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robinson</surname>
                    <given-names>DO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moutou</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kennedy</surname>
                    <given-names>CR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dennis</surname>
                    <given-names>NR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hughes</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ellison</surname>
                    <given-names>DW</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>A clinical and genetic study of a manifesting heterozygote with X-linked myotubular myopathy.</article-title>
                <source>Neuromuscul Disord</source>
                <volume>10</volume>
                <fpage>133</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">10714588</pub-id>
              </element-citation>
            </ref>
            <ref id="mtm.REF.h_ne.1999.77">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>H&#x000e4;ne</surname>
                    <given-names>BG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rogers</surname>
                    <given-names>RC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schwartz</surname>
                    <given-names>CE</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Germline mosaicism in X-linked myotubular myopathy.</article-title>
                <source>Clin Genet</source>
                <volume>56</volume>
                <fpage>77</fpage>
                <lpage>81</lpage>
                <pub-id pub-id-type="pmid">10466421</pub-id>
              </element-citation>
            </ref>
            <ref id="mtm.REF.helliwell.1998.152">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Helliwell</surname>
                    <given-names>TR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ellis</surname>
                    <given-names>IH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Appleton</surname>
                    <given-names>RE</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Myotubular myopathy: morphological, immunohistochemical and clinical variation.</article-title>
                <source>Neuromuscul Disord</source>
                <volume>8</volume>
                <fpage>152</fpage>
                <lpage>61</lpage>
                <pub-id pub-id-type="pmid">9631395</pub-id>
              </element-citation>
            </ref>
            <ref id="mtm.REF.herman.1999.206">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Herman</surname>
                    <given-names>GE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Finegold</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhao</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Gouyon</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Metzenberg</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Medical complications in long-term survivors with X-linked myotubular myopathy.</article-title>
                <source>J Pediatr</source>
                <volume>134</volume>
                <fpage>206</fpage>
                <lpage>14</lpage>
                <pub-id pub-id-type="pmid">9931531</pub-id>
              </element-citation>
            </ref>
            <ref id="mtm.REF.herman.2002.114">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Herman</surname>
                    <given-names>GE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kopacz</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhao</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mills</surname>
                    <given-names>PL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Metzenberg</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Das</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Characterization of mutations in fifty North American patients with X-linked myotubular myopathy.</article-title>
                <source>Hum Mutat</source>
                <volume>19</volume>
                <fpage>114</fpage>
                <lpage>21</lpage>
                <pub-id pub-id-type="pmid">11793470</pub-id>
              </element-citation>
            </ref>
            <ref id="mtm.REF.hnia.2011.70">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hnia</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tronch&#x000e8;re</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tomczak</surname>
                    <given-names>KK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Amoasii</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schultz</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beggs</surname>
                    <given-names>AH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Payrastre</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mandel</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Laporte</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>Myotubularin controls desmin intermediate filament architecture and mitochondrial dynamics in human and mouse skeletal muscle.</article-title>
                <source>J Clin Invest.</source>
                <volume>121</volume>
                <fpage>70</fpage>
                <lpage>85</lpage>
                <pub-id pub-id-type="pmid">21135508</pub-id>
              </element-citation>
            </ref>
            <ref id="mtm.REF.hoffjan.2006.749">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hoffjan</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thiels</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vorgerd</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neuen-Jacob</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Epplen</surname>
                    <given-names>JT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kress</surname>
                    <given-names>W</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Extreme phenotypic variability in a German family with X-linked myotubular myopathy associated with E404K mutation in MTM1.</article-title>
                <source>Neuromuscul Disord</source>
                <volume>16</volume>
                <fpage>749</fpage>
                <lpage>53</lpage>
                <pub-id pub-id-type="pmid">17005396</pub-id>
              </element-citation>
            </ref>
            <ref id="mtm.REF.hu.1996.139">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hu</surname>
                    <given-names>LJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Laporte</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kress</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kioschis</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Siebenhaar</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Poustka</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fardeau</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Metzenberg</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Janssen</surname>
                    <given-names>EA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thomas</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mandel</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dahl</surname>
                    <given-names>N</given-names>
                  </name>
                </person-group>
                <year>1996</year>
                <article-title>Deletions in Xq28 in two boys with myotubular myopathy and abnormal genital development define a new contiguous gene syndrome in a 430 kb region.</article-title>
                <source>Hum Mol Genet</source>
                <volume>5</volume>
                <fpage>139</fpage>
                <lpage>43</lpage>
                <pub-id pub-id-type="pmid">8789451</pub-id>
              </element-citation>
            </ref>
            <ref id="mtm.REF.jungbluth.2003.55">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Jungbluth</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sewry</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Buj-Bello</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kristiansen</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Orstavik</surname>
                    <given-names>KH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kelsey</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Manzur</surname>
                    <given-names>AY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mercuri</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wallgren-Pettersson</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muntoni</surname>
                    <given-names>F</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Early and severe presentation of X-linked myotubular myopathy in a girl with skewed X-inactivation.</article-title>
                <source>Neuromuscul Disord</source>
                <volume>13</volume>
                <fpage>55</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">12467733</pub-id>
              </element-citation>
            </ref>
            <ref id="mtm.REF.kristiansen.2003.468">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kristiansen</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Knudsen</surname>
                    <given-names>GP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tanner</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McEntagart</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jungbluth</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muntoni</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sewry</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gallati</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Orstavik</surname>
                    <given-names>KH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wallgren-Pettersson</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>X-inactivation patterns in carriers of X-linked myotubular myopathy.</article-title>
                <source>Neuromuscul Disord</source>
                <volume>13</volume>
                <fpage>468</fpage>
                <lpage>71</lpage>
                <pub-id pub-id-type="pmid">12899873</pub-id>
              </element-citation>
            </ref>
            <ref id="mtm.REF.laporte.2000.393">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Laporte</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Biancalana</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tanner</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kress</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schneider</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wallgren-Pettersson</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Herger</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Buj-Bello</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blondeau</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liechti-Gallati</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mandel</surname>
                    <given-names>JL</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>MTM1 mutations in X-linked myotubular myopathy.</article-title>
                <source>Hum Mutat</source>
                <volume>15</volume>
                <fpage>393</fpage>
                <lpage>409</lpage>
                <pub-id pub-id-type="pmid">10790201</pub-id>
              </element-citation>
            </ref>
            <ref id="mtm.REF.laporte.2001a.221">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Laporte</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blondeau</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Buj-Bello</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mandel</surname>
                    <given-names>JL</given-names>
                  </name>
                </person-group>
                <year>2001a</year>
                <article-title>The myotubularin family: from genetic disease to phosphoinositide metabolism.</article-title>
                <source>Trends Genet</source>
                <volume>17</volume>
                <fpage>221</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">11275328</pub-id>
              </element-citation>
            </ref>
            <ref id="mtm.REF.laporte.1998a.1703">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Laporte</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blondeau</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Buj-Bello</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tentler</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kretz</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dahl</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mandel</surname>
                    <given-names>JL</given-names>
                  </name>
                </person-group>
                <year>1998a</year>
                <article-title>Characterization of the myotubularin dual specificity phosphatase gene family from yeast to human.</article-title>
                <source>Hum Mol Genet</source>
                <volume>7</volume>
                <fpage>1703</fpage>
                <lpage>12</lpage>
                <pub-id pub-id-type="pmid">9736772</pub-id>
              </element-citation>
            </ref>
            <ref id="mtm.REF.laporte.2002.3105">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Laporte</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blondeau</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gansmuller</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lutz</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vonesch</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mandel</surname>
                    <given-names>JL</given-names>
                  </name>
                </person-group>
                <article-title>The PtdIns3P phosphatase myotubularin is a cytoplasmic protein that also localizes to Rac1-inducible plasma membrane ruffles.</article-title>
                <source>J Cell Sci.</source>
                <year>2002</year>
                <volume>115</volume>
                <fpage>3105</fpage>
                <lpage>17</lpage>
                <pub-id pub-id-type="pmid">12118066</pub-id>
              </element-citation>
            </ref>
            <ref id="mtm.REF.laporte.1998b.325">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Laporte</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guiraud-Chaumeil</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tanner</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blondeau</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hu</surname>
                    <given-names>LJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vicaire</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liechti-Gallati</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mandel</surname>
                    <given-names>JL</given-names>
                  </name>
                </person-group>
                <year>1998b</year>
                <article-title>Genomic organization of the MTM1 gene implicated in X-linked myotubular myopathy.</article-title>
                <source>Eur J Hum Genet</source>
                <volume>6</volume>
                <fpage>325</fpage>
                <lpage>30</lpage>
                <pub-id pub-id-type="pmid">9781038</pub-id>
              </element-citation>
            </ref>
            <ref id="mtm.REF.laporte.1997.1505">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Laporte</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guiraud-Chaumeil</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vincent</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mandel</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tanner</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liechti-Gallati</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wallgren-Pettersson</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dahl</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kress</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bolhuis</surname>
                    <given-names>PA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fardeau</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Samson</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bertini</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <year>1997</year>
                <article-title>Mutations in the MTM1 gene implicated in X-linked myotubular myopathy. ENMC International Consortium on Myotubular Myopathy. European Neuro-Muscular Center.</article-title>
                <source>Hum Mol Genet</source>
                <volume>6</volume>
                <fpage>1505</fpage>
                <lpage>11</lpage>
                <pub-id pub-id-type="pmid">9305655</pub-id>
              </element-citation>
            </ref>
            <ref id="mtm.REF.laporte.1996.175">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Laporte</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hu</surname>
                    <given-names>LJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kretz</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mandel</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kioschis</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Coy</surname>
                    <given-names>JF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Klauck</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Poustka</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dahl</surname>
                    <given-names>N</given-names>
                  </name>
                </person-group>
                <year>1996</year>
                <article-title>A gene mutated in X-linked myotubular myopathy defines a new putative tyrosine phosphatase family conserved in yeast.</article-title>
                <source>Nat Genet</source>
                <volume>13</volume>
                <fpage>175</fpage>
                <lpage>82</lpage>
                <pub-id pub-id-type="pmid">8640223</pub-id>
              </element-citation>
            </ref>
            <ref id="mtm.REF.laporte.2001b.42">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Laporte</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kress</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mandel</surname>
                    <given-names>JL</given-names>
                  </name>
                </person-group>
                <year>2001b</year>
                <article-title>Diagnosis of X-linked myotubular myopathy by detection of myotubularin.</article-title>
                <source>Ann Neurol</source>
                <volume>50</volume>
                <fpage>42</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">11456308</pub-id>
              </element-citation>
            </ref>
            <ref id="mtm.REF.lorenzo.2006.2953">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lorenzo</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Urb&#x000e9;</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Clague</surname>
                    <given-names>MJ</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Systematic analysis of myotubularins: heteromeric interactions, subcellular localisation and endosome related functions.</article-title>
                <source>J Cell Sci.</source>
                <volume>119</volume>
                <fpage>2953</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">16787938</pub-id>
              </element-citation>
            </ref>
            <ref id="mtm.REF.mccrea.2009.483">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>McCrea</surname>
                    <given-names>HJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kretz</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Laporte</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ment</surname>
                    <given-names>LR</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Dementia in a child with myotubular myopathy.</article-title>
                <source>Pediatr Neurol</source>
                <volume>40</volume>
                <fpage>483</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">19433289</pub-id>
              </element-citation>
            </ref>
            <ref id="mtm.REF.mcentagart.2002.939">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>McEntagart</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Parsons</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Buj-Bello</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Biancalana</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fenton</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Little</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Krawczak</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thomas</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Herman</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Clarke</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wallgren-Pettersson</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Genotype-phenotype correlations in X-linked myotubular myopathy.</article-title>
                <source>Neuromuscul Disord</source>
                <volume>12</volume>
                <fpage>939</fpage>
                <lpage>46</lpage>
                <pub-id pub-id-type="pmid">12467749</pub-id>
              </element-citation>
            </ref>
            <ref id="mtm.REF.mejaddam.2009.91">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mejaddam</surname>
                    <given-names>AY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nennesmo</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sejersen</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Severe phenotype of a patient with autosomal recessive centronuclear myopathy due to a BIN1 mutation.</article-title>
                <source>Acta Myol.</source>
                <volume>28</volume>
                <fpage>91</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">20476667</pub-id>
              </element-citation>
            </ref>
            <ref id="mtm.REF.melberg.2010.53">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Melberg</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kretz</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kalimo</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wallgren-Pettersson</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Toussaint</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>B&#x000f6;hm</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>St&#x000e5;lberg</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Laporte</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Adult course in dynamin 2 dominant centronuclear myopathy with neonatal onset.</article-title>
                <source>Neuromuscul Disord.</source>
                <volume>20</volume>
                <fpage>53</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">19932619</pub-id>
              </element-citation>
            </ref>
            <ref id="mtm.REF.nicot.2007.1134">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nicot</surname>
                    <given-names>AS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Toussaint</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tosch</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kretz</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wallgren-Pettersson</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Iwarsson</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kingston</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garnier</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Biancalana</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oldfors</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mandel</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Laporte</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Mutations in amphiphysin 2 (BIN1) disrupt interaction with dynamin 2 and cause autosomal recessive centronuclear myopathy.</article-title>
                <source>Nat Genet.</source>
                <volume>39</volume>
                <fpage>1134</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">17676042</pub-id>
              </element-citation>
            </ref>
            <ref id="mtm.REF.nishino.1998.453">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nishino</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Minami</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kobayashi</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ikezawa</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goto</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arahata</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nonaka</surname>
                    <given-names>I</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>MTM1 gene mutations in Japanese patients with the severe infantile form of myotubular myopathy.</article-title>
                <source>Neuromuscul Disord</source>
                <volume>8</volume>
                <fpage>453</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">9829274</pub-id>
              </element-citation>
            </ref>
            <ref id="mtm.REF.palace.2008.2">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Palace</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beeson</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>The congenital myasthenic syndromes.</article-title>
                <source>J Neuroimmunol.</source>
                <volume>201-202</volume>
                <fpage>2</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">18708269</pub-id>
              </element-citation>
            </ref>
            <ref id="mtm.REF.p_nissonbesnier.2007.180">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>P&#x000e9;nisson-Besnier</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Biancalana</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reynier</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cossee</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dubas</surname>
                    <given-names>F</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Diagnosis of myotubular myopathy in the oldest known manifesting female carrier: a clinical and genetic study.</article-title>
                <source>Neuromuscul Disord</source>
                <volume>17</volume>
                <fpage>180</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">17251023</pub-id>
              </element-citation>
            </ref>
            <ref id="mtm.REF.pierson.2007.562">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pierson</surname>
                    <given-names>CR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Agrawal</surname>
                    <given-names>PB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blasko</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beggs</surname>
                    <given-names>AH</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Myofiber size correlates with MTM1 mutation type and outcome in X-linked myotubular myopathy.</article-title>
                <source>Neuromuscul Disord.</source>
                <volume>17</volume>
                <fpage>562</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">17537630</pub-id>
              </element-citation>
            </ref>
            <ref id="mtm.REF.pierson.2005.555">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pierson</surname>
                    <given-names>CR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tomczak</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Agrawal</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moghadaszadeh</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beggs</surname>
                    <given-names>AH</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>X-linked myotubular and centronuclear myopathies.</article-title>
                <source>J Neuropathol Exp Neurol.</source>
                <volume>64</volume>
                <fpage>555</fpage>
                <lpage>64</lpage>
                <pub-id pub-id-type="pmid">16042307</pub-id>
              </element-citation>
            </ref>
            <ref id="mtm.REF.ribeiro.2011.e1001295">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ribeiro</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yuan</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tanentzapf</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dowling</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kiger</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>Phosphoinositide regulation of integrin trafficking required for muscle attachment and maintenance.</article-title>
                <source>PLoS Genet.</source>
                <volume>7</volume>
                <fpage>e1001295</fpage>
                <pub-id pub-id-type="pmid">21347281</pub-id>
              </element-citation>
            </ref>
            <ref id="mtm.REF.robb.2011.379">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Robb</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sewry</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dowling</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Feng</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cullup</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lillis</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abbs</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lees</surname>
                    <given-names>MM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Laporte</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Manzur</surname>
                    <given-names>AY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Knight</surname>
                    <given-names>RK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mills</surname>
                    <given-names>KR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pike</surname>
                    <given-names>MG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kress</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beeson</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jungbluth</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pitt</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muntoni</surname>
                    <given-names>F</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>Impaired neuromuscular transmission and response to acetylcholinesterase inhibitors in centronuclear myopathies.</article-title>
                <source>Neuromuscul Disord.</source>
                <volume>21</volume>
                <fpage>379</fpage>
                <lpage>86</lpage>
                <pub-id pub-id-type="pmid">21440438</pub-id>
              </element-citation>
            </ref>
            <ref id="mtm.REF.robinson.2006.403">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Robinson</surname>
                    <given-names>FL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dixon</surname>
                    <given-names>JE</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Myotubularin phosphatases: policing 3-phosphoinositides.</article-title>
                <source>Trends Cell Biol.</source>
                <volume>16</volume>
                <fpage>403</fpage>
                <lpage>12</lpage>
                <pub-id pub-id-type="pmid">16828287</pub-id>
              </element-citation>
            </ref>
            <ref id="mtm.REF.romero.2010.223">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Romero</surname>
                    <given-names>NB</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Centronuclear myopathies: a widening concept.</article-title>
                <source>Neuromuscul Disord.</source>
                <volume>20</volume>
                <fpage>223</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">20181480</pub-id>
              </element-citation>
            </ref>
            <ref id="mtm.REF.sarnat.1990.109">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sarnat</surname>
                    <given-names>HB</given-names>
                  </name>
                </person-group>
                <year>1990</year>
                <article-title>Myotubular myopathy: arrest of morphogenesis of myofibres associated with persistence of fetal vimentin and desmin. Four cases compared with fetal and neonatal muscle.</article-title>
                <source>Can J Neurol Sci</source>
                <volume>17</volume>
                <fpage>109</fpage>
                <lpage>23</lpage>
                <pub-id pub-id-type="pmid">2357647</pub-id>
              </element-citation>
            </ref>
            <ref id="mtm.REF.schara.2003.1363">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Schara</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kress</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tucke</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mortier</surname>
                    <given-names>W</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>X-linked myotubular myopathy in a female infant caused by a new MTM1 gene mutation.</article-title>
                <source>Neurology</source>
                <volume>60</volume>
                <fpage>1363</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">12707446</pub-id>
              </element-citation>
            </ref>
            <ref id="mtm.REF.senderek.2003.349">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Senderek</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bergmann</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weber</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ketelsen</surname>
                    <given-names>UP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schorle</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rudnik-Schoneborn</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Buttner</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Buchheim</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zerres</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Mutation of the SBF2 gene, encoding a novel member of the myotubularin family, in Charcot-Marie-Tooth neuropathy type 4B2/11p15.</article-title>
                <source>Hum Mol Genet</source>
                <volume>12</volume>
                <fpage>349</fpage>
                <lpage>56</lpage>
                <pub-id pub-id-type="pmid">12554688</pub-id>
              </element-citation>
            </ref>
            <ref id="mtm.REF.sewry.1998.394">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sewry</surname>
                    <given-names>CA</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>The role of immunocytochemistry in congenital myopathies.</article-title>
                <source>Neuromuscul Disord</source>
                <volume>8</volume>
                <fpage>394</fpage>
                <lpage>400</lpage>
                <pub-id pub-id-type="pmid">9713857</pub-id>
              </element-citation>
            </ref>
            <ref id="mtm.REF.sewry.2008.569">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sewry</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jimenez-Mallebrera</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muntoni</surname>
                    <given-names>F</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Congenital myopathies.</article-title>
                <source>Curr Opin Neurol.</source>
                <volume>21</volume>
                <fpage>569</fpage>
                <lpage>75</lpage>
                <pub-id pub-id-type="pmid">18769251</pub-id>
              </element-citation>
            </ref>
            <ref id="mtm.REF.susman.2010.229">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Susman</surname>
                    <given-names>RD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Quijano-Roy</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yang</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Webster</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Clarke</surname>
                    <given-names>NF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dowling</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kennerson</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nicholson</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Biancalana</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ilkovski</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Flanigan</surname>
                    <given-names>KM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arbuckle</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Malladi</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robinson</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vucic</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mayer</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Romero</surname>
                    <given-names>NB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Urtizberea</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garc&#x000ed;a-Bragado</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guicheney</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bitoun</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carlier</surname>
                    <given-names>RY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>North</surname>
                    <given-names>KN</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Expanding the clinical, pathological and MRI phenotype of DNM2-related centronuclear myopathy.</article-title>
                <source>Neuromuscul Disord.</source>
                <volume>20</volume>
                <fpage>229</fpage>
                <lpage>37</lpage>
                <pub-id pub-id-type="pmid">20227276</pub-id>
              </element-citation>
            </ref>
            <ref id="mtm.REF.sutton.2001.900">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sutton</surname>
                    <given-names>IJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Winer</surname>
                    <given-names>JB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Norman</surname>
                    <given-names>AN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liechti-Gallati</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>MacDonald</surname>
                    <given-names>F</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Limb girdle and facial weakness in female carriers of X-linked myotubular myopathy mutations.</article-title>
                <source>Neurology</source>
                <volume>57</volume>
                <fpage>900</fpage>
                <lpage>2</lpage>
                <pub-id pub-id-type="pmid">11552027</pub-id>
              </element-citation>
            </ref>
            <ref id="mtm.REF.tanner.1998.62">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tanner</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Laporte</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guiraud-Chaumeil</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liechti-Gallati</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Confirmation of prenatal diagnosis results of X-linked recessive myotubular myopathy by mutational screening, and description of three new mutations in the MTM1 gene.</article-title>
                <source>Hum Mutat</source>
                <volume>11</volume>
                <fpage>62</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">9450905</pub-id>
              </element-citation>
            </ref>
            <ref id="mtm.REF.tanner.1999a.249">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tanner</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Orstavik</surname>
                    <given-names>KH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kristiansen</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lev</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lerman-Sagie</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sadeh</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liechti-Gallati</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>1999a</year>
                <article-title>Skewed X-inactivation in a manifesting carrier of X-linked myotubular myopathy and in her non-manifesting carrier mother.</article-title>
                <source>Hum Genet.</source>
                <volume>104</volume>
                <fpage>249</fpage>
                <lpage>53</lpage>
                <pub-id pub-id-type="pmid">10323249</pub-id>
              </element-citation>
            </ref>
            <ref id="mtm.REF.tanner.1999b.41">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tanner</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schneider</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thomas</surname>
                    <given-names>NS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Clarke</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lazarou</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liechti-Gallati</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>1999b</year>
                <article-title>Characterization of 34 novel and six known MTM1 gene mutations in 47 unrelated X-linked myotubular myopathy patients.</article-title>
                <source>Neuromuscul Disord</source>
                <volume>9</volume>
                <fpage>41</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">10063835</pub-id>
              </element-citation>
            </ref>
            <ref id="mtm.REF.taylor.2000.8910">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Taylor</surname>
                    <given-names>GS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maehama</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dixon</surname>
                    <given-names>JE</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Inaugural article: myotubularin, a protein tyrosine phosphatase mutated in myotubular myopathy, dephosphorylates the lipid second messenger, phosphatidylinositol 3-phosphate.</article-title>
                <source>Proc Natl Acad Sci U S A</source>
                <volume>97</volume>
                <fpage>8910</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">10900271</pub-id>
              </element-citation>
            </ref>
            <ref id="mtm.REF.tosch.2006.3098">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tosch</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rohde</surname>
                    <given-names>HM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tronch&#x000e8;re</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zanoteli</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Monroy</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kretz</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dondaine</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Payrastre</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mandel</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Laporte</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>A novel PtdIns3P and PtdIns(3,5)P2 phosphatase with an inactivating variant in centronuclear myopathy.</article-title>
                <source>Hum Mol Genet.</source>
                <volume>15</volume>
                <fpage>3098</fpage>
                <lpage>106</lpage>
                <pub-id pub-id-type="pmid">17008356</pub-id>
              </element-citation>
            </ref>
            <ref id="mtm.REF.tosch.2010.375">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tosch</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vasli</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kretz</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nicot</surname>
                    <given-names>AS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gasnier</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dondaine</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oriot</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barth</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Puissant</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Romero</surname>
                    <given-names>NB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonnemann</surname>
                    <given-names>CG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heller</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Duval</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Biancalana</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Laporte</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Novel molecular diagnostic approaches for X-linked centronuclear (myotubular) myopathy reveal intronic mutations.</article-title>
                <source>Neuromuscul Disord</source>
                <volume>20</volume>
                <fpage>375</fpage>
                <lpage>81</lpage>
                <pub-id pub-id-type="pmid">20434914</pub-id>
              </element-citation>
            </ref>
            <ref id="mtm.REF.toussaint.2011.253">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Toussaint</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cowling</surname>
                    <given-names>BS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hnia</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mohr</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oldfors</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schwab</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yis</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maisonobe</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stojkovic</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wallgren-Pettersson</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Laugel</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Echaniz-Laguna</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mandel</surname>
                    <given-names>J-L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nishino</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Laporte</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>Defects in amphiphysin 2 (Bin1) and triads in several forms of centronuclear myopathies.</article-title>
                <source>Acta Neuropathol</source>
                <volume>121</volume>
                <fpage>253</fpage>
                <lpage>66</lpage>
                <pub-id pub-id-type="pmid">20927630</pub-id>
              </element-citation>
            </ref>
            <ref id="mtm.REF.tsai.2005.245">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tsai</surname>
                    <given-names>TC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Horinouchi</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Noguchi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Minami</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Murayama</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hayashi</surname>
                    <given-names>YK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nonaka</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nishino</surname>
                    <given-names>I</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Characterization of MTM1 mutations in 31 Japanese families with myotubular myopathy, including a patient carrying 240 kb deletion in Xq28 without male hypogenitalism.</article-title>
                <source>Neuromuscul Disord</source>
                <volume>15</volume>
                <fpage>245</fpage>
                <lpage>52</lpage>
                <pub-id pub-id-type="pmid">15725586</pub-id>
              </element-citation>
            </ref>
            <ref id="mtm.REF.tsujita.2004.13817">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tsujita</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Itoh</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ijuin</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yamamoto</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shisheva</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Laporte</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takenawa</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Myotubularin regulates the function of the late endosome through the gram domain-phosphatidylinositol 3,5-bisphosphate interaction.</article-title>
                <source>J Biol Chem</source>
                <volume>279</volume>
                <fpage>13817</fpage>
                <lpage>24</lpage>
                <pub-id pub-id-type="pmid">14722070</pub-id>
              </element-citation>
            </ref>
            <ref id="mtm.REF.vincent.1998.241">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Vincent</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guiraud-Chaumeil</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Laporte</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Manouvrier-Hanu</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mandel</surname>
                    <given-names>JL</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Extensive germinal mosaicism in a family with X-linked myotubular myopathy simulates genetic heterogeneity.</article-title>
                <source>J Med Genet</source>
                <volume>35</volume>
                <fpage>241</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">9541111</pub-id>
              </element-citation>
            </ref>
            <ref id="mtm.REF.wallgrenpettersson.1998.521">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wallgren-Pettersson</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>58th ENMC workshop: myotubular myopathy 20-22 March, 1998, Naarden, The Netherlands.</article-title>
                <source>Neuromuscul Disord</source>
                <volume>8</volume>
                <fpage>521</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">9829284</pub-id>
              </element-citation>
            </ref>
            <ref id="mtm.REF.wallgrenpettersson.2000.525">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wallgren-Pettersson</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>72nd ENMC International Workshop: myotubular myopathy 1-3 October 1999, Hilversum, The Netherlands.</article-title>
                <source>Neuromuscul Disord</source>
                <volume>10</volume>
                <fpage>525</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">10996786</pub-id>
              </element-citation>
            </ref>
            <ref id="mtm.REF.wallgrenpettersson.1995.673">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wallgren-Pettersson</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Clarke</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Samson</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fardeau</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dubowitz</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moser</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grimm</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barohn</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barth</surname>
                    <given-names>PG</given-names>
                  </name>
                </person-group>
                <year>1995</year>
                <article-title>The myotubular myopathies: differential diagnosis of the X linked recessive, autosomal dominant, and autosomal recessive forms and present state of DNA studies.</article-title>
                <source>J Med Genet</source>
                <volume>32</volume>
                <fpage>673</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">8544184</pub-id>
              </element-citation>
            </ref>
            <ref id="mtm.REF.wang.2001.1456">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>SY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ruggles</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vade</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Newman</surname>
                    <given-names>BM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Borge</surname>
                    <given-names>MA</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Hepatic rupture caused by peliosis hepatis.</article-title>
                <source>J Pediatr Surg</source>
                <volume>36</volume>
                <fpage>1456</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">11528627</pub-id>
              </element-citation>
            </ref>
            <ref id="mtm.REF.wilmshurst.2010.717">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wilmshurst</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lillis</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhou</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pillay</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Henderson</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kress</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>M&#x000fc;ller</surname>
                    <given-names>CR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ndondo</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cloke</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cullup</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bertini</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boennemann</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Straub</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Quinlivan</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dowling</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Al-Sarraj</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Treves</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abbs</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Manzur</surname>
                    <given-names>AY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sewry</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muntoni</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jungbluth</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>RYR1 mutations are a common cause of congenital myopathies with central nuclei.</article-title>
                <source>Ann Neurol.</source>
                <volume>68</volume>
                <fpage>717</fpage>
                <lpage>26</lpage>
                <pub-id pub-id-type="pmid">20839240</pub-id>
              </element-citation>
            </ref>
            <ref id="mtm.REF.yu.2003.148">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Yu</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Manson</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>White</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bourne</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Waddy</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Davis</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haan</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>X-linked myotubular myopathy in a family with three adult survivors.</article-title>
                <source>Clin Genet</source>
                <volume>64</volume>
                <fpage>148</fpage>
                <lpage>52</lpage>
                <pub-id pub-id-type="pmid">12859411</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
        <sec id="mtm.Suggested_Reading">
          <title>Suggested Reading</title>
          <ref-list id="mtm.Suggested_Reading.reflist0">
            <ref id="mtm.REF.claeys.2010.519">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Claeys</surname>
                    <given-names>KG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maisonobe</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>B&#x000f6;hm</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Laporte</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hezode</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Romero</surname>
                    <given-names>NB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brochier</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bitoun</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carlier</surname>
                    <given-names>RY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stojkovic</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Phenotype of a patient with recessive centronuclear myopathy and a novel BIN1 mutation.</article-title>
                <source>Neurology.</source>
                <volume>74</volume>
                <fpage>519</fpage>
                <lpage>21</lpage>
                <pub-id pub-id-type="pmid">20142620</pub-id>
              </element-citation>
            </ref>
            <ref id="mtm.REF.jungbluth.2009">
              <mixed-citation publication-type="confproc">Jungbluth H, Wallgren-Pettersson C, Laporte JF, on behalf of the Centronuclear (Myotubular) Myopathy Consortium (2009) 164th ENMC International workshop: 6th workshop on centronuclear (myotubular) myopathies, 16-18th January 2009, Naarden, The Netherlands. Neuromuscul Disord 19:721-9</mixed-citation>
            </ref>
            <ref id="mtm.REF.jungbluth.2008.26">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Jungbluth</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wallgren-Petersson</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Laporte</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Centronuclear (myotubular) myopathy.</article-title>
                <source>Orphanet J Rare Dis</source>
                <volume>3</volume>
                <fpage>26</fpage>
                <pub-id pub-id-type="pmid">18817572</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="mtm.Chapter_Notes">
        <title>Chapter Notes</title>
        <p>
          <bold>Author History</bold>
        </p>
        <p>Soma Das, PhD (2002-present)James Dowling, MD, PhD (2011-present)Gail Ellen Herman, MD, PhD; Nationwide Children&#x02019;s Hospital, Columbus (2002-2011)Christopher R Pierson, MD, PhD (2011-present)</p>
        <sec id="mtm.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>6 October 2011 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>5 October 2006 (me) Comprehensive update posted to live Web site</p>
            </list-item>
            <list-item>
              <p>3 May 2004 (me) Comprehensive update posted to live Web site</p>
            </list-item>
            <list-item>
              <p>25 February 2002 (me) Review posted to live Web site</p>
            </list-item>
            <list-item>
              <p>2 October 2001 (gh) Original submission</p>
            </list-item>
          </list>
        </sec>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
